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ABSTRACT 
 
William R. Thelin:  The regulation of CFTR by protein-protein interactions 
 
(Under the direction of Dr. Sharon L. Milgram) 
 
 
 
 Cystic fibrosis (CF) is an autosomal recessive disease resulting from the mis-
regulation of epithelial ion transport.  CF is caused by mutations in the cystic fibrosis 
transmembrane conductance regulator (CFTR), an apical membrane chloride channel 
expressed in polarized epithelial cells.  To identify factors that regulate CFTR activity, we 
utilized biochemical and proteomics approaches to identify novel CFTR binding proteins.   
We find that the C-terminus of CFTR directly interacts with the serine/threonine 
phosphatase PP2A.  PP2A is a heterotrimeric phosphatase composed of a catalytic subunit 
and two divergent regulatory subunits (A and B), which mediate the cellular localization and 
substrate specificity of the enzyme.  By mass spectrometry, we identified the exact PP2A 
regulatory subunits associated with CFTR as Aα and B’ε, and find that the B’ε subunit binds 
CFTR directly.  PP2A subunits localize to the apical surface of airway epithelia and PP2A 
phosphatase activity co-purifies with CFTR in Calu-3 cells.  In functional assays, PP2A 
inhibition blocks the rundown of basal CFTR currents and increases channel activity in 
excised patches of airway epithelia and in intact mouse jejunum.  Moreover, PP2A inhibition 
increases the pericilliary liquid in cultures of well differentiated human bronchial epithelial 
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cells by a CFTR-dependent mechanism. Thus, PP2A is a relevant CFTR phosphatase in 
epithelial tissues and may be a clinically relevant drug target for CF. 
Additionally, the N-terminus of CFTR directly interacts with two actin binding 
proteins, filamin A and filamin B.  In polarized epithelial cells, filamins are highly localized 
to the sub-apical compartment where they likely interact with CFTR at or near the plasma 
membrane.  We find that CFTR and filamins specifically interact by co-immunoprecipitation 
and that a disease-causing mutation in CFTR, serine 13 to phenylalanine (S13F), disrupts this 
interaction.  Consistent with the loss of cytoskeletal anchorage, S13F CFTR displays 
decreased cell surface levels and less confinement at the plasma membrane relative to wild-
type CFTR.  Furthermore, S13F CFTR is more rapidly degraded compared to wild-type 
CFTR which correlates with the accumulation of S13F CFTR in the lysosomes.  Taken 
together, these data suggest the filamins regulate the cell surface stability and endocytic 
trafficking of CFTR.  
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Chapter 1: The physiology of CFTR 
 
 Epithelial cells provide a physical barrier which regulates the flow of substances 
between an organism and its environment.  Epithelia function to prevent bacteria and other 
harmful substances from accessing the blood stream.  Furthermore, epithelial cells must 
balance their protective function with the selective uptake of nutrients and electrolytes.  The 
ability of epithelial cells to function as a barrier and transport tissue is derived from their 
polarized nature.  The apical (lumenal) plasma membrane of epithelial cells is physically 
separated from the basolateral (serosal) membranes by tight junctions (Nelson et al., 1992; 
Wollner and Nelson, 1992).  Receptors, ion channels, and lipids are transported to selective 
membrane domains, giving rise to the polarized distribution of signaling and transport 
molecules.  This segregation of cell surface proteins allows epithelia to achieve the vectorial 
transport of water, ions, and other solutes.     
 The lungs are chronically exposed to pathogens and other noxious particles through 
normal tidal breathing.  Airway epithelial cells provide a first line of innate host defense by 
regulating an elaborate clearance mechanism.  In the lungs, the lumenal surface is covered by 
a thin film known as the airway surface liquid (ASL) composed of a mix of gel and sol 
(Widdicombe, 1989).  The mucus gel is primarily composed of mucins, which are high 
molecular weight glycoproteins secreted by goblet cells.  The mucus layer traps bacteria and 
inhaled particles preventing them from accessing the airway cells.  The high carbohydrate 
content and oligosaccharide diversity of mucins is thought to facilitate bacterial adhesion 
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(Thornton et al., 1991).  In addition to a purely passive role, antimicrobial peptides known as 
defensins are secreted into the mucus where they are proposed to disrupt bacterial cell walls 
by forming membrane pores (Chilvers and O'Callaghan, 2000).  Mucus clearance is regulated 
by ciliated epithelial cells which propel the mucus through the upper airways where it is 
swallowed or expectorated.  The normal function of airway cilia is dependent upon the 
composition of periciliary fluid (PCL) underlying the mucus layer.  The PCL provides a low 
viscosity fluid which facilitates ciliary movement and is critical for mucociliary clearance 
(Tarran et al., 2001). 
 Diseases which disrupt mucociliary clearance, such as cystic fibrosis (CF) or primary 
ciliary dyskinesia, significantly increase susceptibility to life-threatening infections.  CF is 
caused by mutations in the gene encoding the cystic fibrosis transmembrane conducatance 
regulator, an apical membrane chloride channel (Riordan et al., 1989).  The loss of CFTR 
function results in an imbalance of salt and water transport in airway epithelial cells.  This 
imbalance prevents the efficient clearance of mucus in the lungs ultimately leading to the 
formation of thick mucus plugs in the lower airways (Quinton, 1999).  Opportunistic 
pathogens, such as Pseudomonas aeruginosa, colonize the mucus causing lung infections 
(Kubesch et al., 1993).  In CF patients, chronic lung infection is the primary cause of 
morbidity.    
Prior to the cloning of the gene encoding CFTR, many pioneering studies had 
identified that CF was caused by the loss of a cAMP-dependent chloride conductance which 
likewise altered the transport of other ions such as sodium and bicarbonate (Poulsen et al., 
1994; Smith et al., 1996; Stutts et al., 1997).  In addition to a loss of apical chloride efflux, 
CF epithelia exhibit significantly increased sodium absorption.  Currently, there are two 
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prominent hypotheses which attempt to link the defect in ion transport to chronic lung 
infections.  The “compositional” hypothesis suggests that, in the absence of CFTR, epithelial 
cell absorption of NaCl is decreased, thereby resulting in an increased NaCl concentration in 
the ASL.  At NaCl concentrations exceeding 100 mM, the function of the antimicrobial 
defensins is impaired.  Thus, the “compositional” hypothesis predicts that in the absence of 
functional defensins, bacteria are able to colonize the mucus layer leading to infection.  
Smith et al. found that bacterial did not efficiently grow when placed on the apical surface of 
well-differentiated primary airway epithelial (WD-PAE) cells (Smith et al., 1996).  However, 
the mucus from CF cultures did not inhibit bacterial growth suggesting that the antimicrobial 
properties were impaired.  Consistent with the “compositional” hypothesis, adding water to 
the apical surface of the CF cultures to decrease the salt concentration restored the ability of 
the mucus to inhibit bacterial growth (Smith et al., 1996).  A second hypothesis, known as 
the “volume” hypothesis suggests that the ASL height, not ASL composition, is impaired in 
CF airways.  The “volume” hypothesis proposes that a dominant role of CFTR is to 
negatively regulate the activity of the epithelial sodium channel (ENaC).  Based on 
observations that the activity of the epithelial sodium channel is significantly increased in CF 
airways, this model predicts that isotonic salt transport results in a volume-depleted ALS 
(Stutts et al., 1997).  Furthermore, decreases in ASL volume affect mucociliary clearance 
two-fold.  First, the PCL height is reduced which impairs ciliary movements.  Secondly, the 
mucus layer becomes more viscous and is therefore more difficult to clear.  Thus, mucus 
accumulates in the lower airway which supports bacterial colonization.  Recently, Mall et al. 
provided strong support for the “volume” hypothesis by producing a CF-like phenotype in 
transgenic mice over-expressing ENaC subunits (Mall et al., 2004).  One could imagine that 
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measuring the salt concentrations of ASL derived from normal or CF airways would 
distinguish between the “compositional” and “volume” models.  However, the thin layer of 
ASL has proven difficult to collect and analyze (Tarran et al., 2001).  Alternatively, newer 
approaches in which the ASL of WD-PAE cultures is labeled with fluorescent dextrans and 
measured by confocal microscopy has provided a powerful means to study ASL volume.  
Using this approach Tarran et al. found that the inhibition of CFTR results in a dramatic 
decrease in ASL height (from 13 µM to 7 µM), while CFTR activation increases ASL height 
(Tarran et al., 2005).  These data provide strong evidence that CFTR activity is directly 
coupled to the regulation of ASL volume.   
In 1989, Riordan et al. reported the cloning of the gene encoding CFTR which led to 
a rapid increase in our understanding of this disease (Riordan et al., 1989).  Based on 
sequence similarity, it was evident that CFTR is a member of the ATP-binding cassette 
(ABC) transporter superfamily.  ABC transporters include a large number of proteins (48 
ABC transporter genes in humans alone) found in both prokaryotic and eukaryotic organisms 
which transport a diversity of substrates including ions, peptides, lipids, and other solutes.  
CFTR, like other ABC transporters, is topologically composed of two membrane-spanning 
domains (MSD), which form the membrane pore, and two nucleotide binding domains 
(NBDs) (Riordan et al., 1989).  The NBDs contain sequences predicted to bind and 
hydrolyze MgATP, such as the Walker A, Walker B, and LSGGQ motifs.  In addition, CFTR 
is dually glycosylated on asparagine residues 894 and 900 in the 4th extracellular loop, which 
may have a role in CFTR folding and degradation (Cheng et al., 1990) (Figure 1.1). 
Since the identification of the gene encoding CFTR, more than 1,000 different 
disease-causing mutations have been identified in CF patients.  The CFTR mutations are  
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Figure 1.1.  CFTR is an ABC transport protein 
Similar to other ABC transporters, CFTR contains two membrane spanning domains 
composed of six transmembrane domains and two nucleotide binding domains which 
hydrolyze ATP to ADP.  Unlike other ABC transporters, CFTR has a unique cytosolic 
regulatory domain which regulates channel gating. 
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functionally categorized by defects in early biosynthesis and folding (Class I, II, and V) or 
chloride channel activity (Class III and IV) (Welsh and Smith, 1993; Zielenski and Tsui, 
1995).  Class I mutations are caused by nonsense mutations which prematurely truncate the 
protein.  Class II mutations interfere with the folding of CFTR in the endoplasmic reticulum 
(ER).  As a result, CFTR is retained in the ER where it is eventually targeted for degradation 
by the ER-associated degradation pathway (ERAD).  Class II mutations are the most 
common and include the ∆F508 (deletion of phenylalanine 508) mutation found in ~70% of 
all CF patients.  Class III and IV mutations affect channel regulation at the cell surface.  For 
example, the G551D, a class III mutation, occurs in the LSGGQ motif in NBD1 and severely 
impairs channel gating (Delaney et al., 1996; Oceandy et al., 2003; Oceandy et al., 2002).  
Class IV mutations, such as R117H, result in altered channel conductance.  Finally, class V 
mutations result in reduced CFTR mRNA and, therefore, reduced protein (Zielenski and 
Tsui, 1995).  More recently, Haardt et al. proposed a new class of CFTR mutations (Class 
VI) which cause the premature degradation of CFTR in a post-ER compartment (Haardt et 
al., 1999).  The class VI mutations are based on the observation that CFTR proteins lacking 
at least the last 80 C-terminal amino acids are rapidly retrieved from the cell surface and 
degraded through a ubiquitin-dependent pathway. 
Initial studies in cells which lacked a CFTR-like activity including Chinese Hamster 
ovary (CHO) (Anderson et al., 1991b), HeLa (Gregory et al., 1990), NIH-3T3 (Anderson et 
al., 1991b), and Xenopus oocytes (Bear et al., 1991) demonstrated that the expression of 
CFTR produced a unique cAMP-dependent chloride conductance.  Furthermore, in excised 
membrane patches, the chloride channel activity of CFTR was shown to require the activity 
of the cAMP-dependent protein kinase (PKA) and MgATP (Anderson et al., 1991a).  For 
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other ABC transporters, ATP hydrolysis at the NBDs provides the energy to actively 
transport substances across the plasma membrane.  Initially, it was not clear why CFTR 
required the NBDs as chloride is passively transported through CFTR down a favorable 
concentration gradient.  However, it is now clear that the hydrolysis of ATP by the NBDs 
provide the driving force for channel opening (Baukrowitz et al., 1994).  The requirement for 
PKA activity comes from the unique CFTR regulatory domain (R domain).  The CFTR R 
domain is a 272 amino acid stretch which separates NBD1 from MSD2.  The R domain 
contains multiple di-basic PKA consensus phosphorylation motifs.  As such, PKA can 
phosphorylate the CFTR R domain at least 10 times (Seibert et al., 1995).  The 
phosphorylation of the R domain increases the rate of ATP hydrolysis by the NBDs and 
thereby increases channel opening (Howell et al., 2004) (Figure 1.2).  The phosphorylation of 
the R domain is thought to induce a conformational change in CFTR which may promote 
interactions between NBD1 and NBD2 (Howell et al., 2004).  In studies designed to examine 
the phosphorylation-dependent structural changes in R domain structure, Ostedgaard et al. 
found that the R domain is relatively unstructured in solution (Ostedgaard et al., 2000). 
Presently, it is not clear whether the R domain functions as an activation domain or inhibitory 
domain.  The addition of exogenous R domain proteins blocked CFTR channel activity in 
patches, suggesting an inhibitory function (Ma et al., 1996).  However, the R domain likely 
functions to stimulate channel activity as its phosphorylation potentiates CFTR activity to 
higher levels than CFTR mutants which do not require phosphorylation for gating 
(Baldursson et al., 2001).  While the importance of the R domain with respect to CFTR 
channel activity is well appreciated, the mechanism by which the R domain functions is not 
understood.  Current studies using structural, biochemical, and electrophysiological 
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Figure 1.2  CFTR is activated downstream of adenosine receptor activation 
In airway epithelia, the activation of CFTR is thought to be predominately regulated by 
extracellular adenosine.  Activation of the adenosine receptor leads to the generation of 
cAMP by membrane bound adenylyl cyclases.  The catalytic subunit of PKA binds to cAMP 
and is released from the regulatory subunits where it can phosphorylate the CFTR R domain.  
The CFTR R domain can be phosphorylated at least 10 times by PKA which potently 
stimulates channel opening. 
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approaches are addressing how the R domain physically associates with the NBDs and how 
R domain phosphorylation influences these interactions. 
 The channel activity of CFTR is tightly controlled by a balance of kinase and 
phosphatase activity.  CFTR is predominantly activated by PKA phosphorylation.  However, 
other kinases have also been shown to regulate CFTR including Ca2+-dependent and 
independent PKC isoforms (Chappe et al., 2003; Dahan et al., 2001; Liedtke et al., 2002), the 
cGMP dependent protein kinase II (cGKII) (Dahan et al., 2001), and the tyrosine kinase c-
Src (Fischer and Machen, 1996).  When added exogenously to patch preparations, PKC 
stimulates CFTR activity.  However, the magnitude of CFTR activation by PKC alone is only 
~15% of that by PKA (Chang et al., 1993).  More importantly, Jia et al. showed that PKC 
phosphorylation was critical for the potentiation of CFTR channel activity by PKA (Jia et al., 
1997).  Based on these studies, they proposed a model whereby the constitutive 
phosphorylation of CFTR by PKC is required for PKA dependent activation of the channel.  
In addition, cGKII phosphorylation of CFTR activates the channel comparably to PKA 
activation (Dahan et al., 2001).  However, the kinetics of cGKII phosphorylation is slower 
than PKA which has been predicted to reflect the initial requirement of membrane 
association for activated cGKII.  The addition of the tyrosine kinase c-Src in excised patches 
increases CFTR gating; however, the physiological significance of Src-mediated CFTR 
regulation is not clear (Fischer and Machen, 1996). 
The signaling pathways which activate CFTR in vivo are tissue dependent.  In the 
airways, CFTR is predominantly activated by adenosine receptor (A2B) signaling, a Gs 
coupled G-protein coupled receptor (Eidelman et al., 1992).  Activation of the A2B receptor 
by leads to the generation of cAMP by membrane bound adenylate cyclases.  PKA is  
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Figure 1.3  CFTR channel gating reflects the balance of endogenous kinase and 
phosphatase activity  
The phosphorylation of the CFTR R domain by kinases such as PKA, PKC, and cGK-II 
cause a conformational change in the channel increasing the efficiency of ATP hydrolysis by 
the NBDs.  ATP hydrolysis provides the driving force for channel opening.  The 
dephosphorylation of CFTR by serine-threonine phosphatases such as PP2A, PP2B, and 
PP2C deactivate the channel. 
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activated in response to the elevated cAMP levels, leading to CFTR phosphorylation and 
increased channel gating (Figure 1.3).  CFTR can also be potently activated by the B2-
adrenergic receptor (β2AR) similarly to the A2B receptor.  The β2AR can activate CFTR in 
tissues such as sweat ducts.  However, it is not clear whether the β2AR is a physiologically 
relevant activator of CFTR in the airways.  In the intestines, CFTR is alternatively activated 
through cyclic GMP signaling pathways.  Guanylate cyclase C (GCC) is an integral 
membrane guanylate cyclase expressed in the gut.  GCC converts GTP into cGMP, in 
response to ligands such as guanylin or uroguanylin (Li et al., 1995b).  CFTR is activated 
downstream of GCC activation by the cooperative actions of cGKII and PKA (Tien et al., 
1994).  In addition to its endogenous ligands, GCC is activated by heat stable enterotoxins 
(STa) elaborated by strains of pathogenic E. coli (Schultz et al., 1990).  STa activation of 
GCC results in apical chloride efflux through CFTR, as well as, the inhibition of sodium 
transport through the sodium hydrogen exchange regulatory factor 3 (NHE-3).  The net result 
of this signaling pathway is increased salt in the intestinal lumen. This likewise provides a 
driving force for water movement into the lumen resulting in secrectory diarrhea (Zhang et 
al., 1999).  In less developed countries, secretory diarrhea is a life-threatening health concern. 
While the activation of CFTR has been extensively studied, much less is known about 
channel deactivation.  Once it was clear that CFTR activity required kinase activity, 
phosphatases were obvious candidates for negative channel regulators.  Work from many 
labs suggests that multiple phosphatases including PP2A, PP2B, PP2C, and alkaline 
phosphatase are involved in the deactivation of CFTR (Luo et al., 1998; Reddy and Quinton, 
1996).  Based on studies using exogenous phosphatases, PP2A and PP2C are the most 
effective at dephosphorylating CFTR in vitro (Berger et al., 1993).  Furthermore, when added 
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to patch preparations, purified PP2A and PP2C both inactivate maximally phosphorylated 
CFTR (Luo et al., 1998).  However, PP2C altered channel openings, while PP2A shortened 
CFTR burst duration.  These data suggest that PP2A and PP2C distinctly regulate CFTR 
channel activity.  Cell permeable phosphatase inhibitors have been used to study CFTR 
deactivation in intact cells.  In human sweat ducts, cardiac myocytes, 3T3 fibroblasts, and Hi-
5 insect cells, inhibitors of PP2A, such as okadaic acid and calyculin A, increase CFTR 
channel activity (Becq et al., 1994; Luo et al., 1998; Yang et al., 1997).  In contrast, PP2A 
inhibitors were observed to have little effect on the rapid deactivation of maximally 
phosphorylated CFTR in T84 intestinal epithelial cells and human airway epithelial cells 
(Travis et al., 1997; Zhu et al., 1999).  However, the role of PP2A in the regulation of CFTR 
in polarized epithelia has not been well characterized.  In baby hamster kidney cells (BHK), 
PP2C co-immunoprecipitates with exogenous CFTR (Zhu et al., 1999).  Additionally, PP2C 
overexpression in Fischer rat thyroid cells (FRT) decreases CFTR chloride conductance 
(Travis et al., 1997).  However, the ability of endogenous PP2C to regulate CFTR in native 
epithelial tissues is unclear as no PP2C inhibitors have been identified.  Furthermore, studies 
in NIH-3T3 fibroblasts suggest that the inhibition of PP2B also stimulates CFTR channel 
activity (Fischer et al., 1998).  However, it is not clear if PP2B is a relevant CFTR 
phosphatase in vivo. 
To date, many signaling molecules able to regulate CFTR have been identified.  
However, the ability of many of these protein kinases and phosphatases to modulate CFTR 
activity has been studied in heterologous expression systems, which may not accurately 
recapitulate the epithelial-specific regulation of CFTR.  In polarized epithelia, CFTR is 
tightly regulated in a defined apical compartment which reflects the organization of CFTR 
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into protein complexes with regulatory factors.  Furthermore, it is now appreciated that all 
aspects of CFTR biology are regulated by direct and indirect protein interactions.  The study 
of CFTR protein interactions has provided a great deal of insight into the processes which 
regulate CFTR biogenesis, trafficking, and channel gating.  The remainder of this chapter 
recounts much of what is known regarding the proteins that directly interact with CFTR.   
 
Multiple protein interactions regulate the CFTR folding and stability 
Genetic and biochemical screens for CFTR-interacting proteins have provided 
significant insights into the chaperone proteins which associate with CFTR including heat 
shock protein 40 (Hsp40), Hsp70, Hsp90, cysteine string protein (CSP), and calnexin 
(Farinha et al., 2002; Loo et al., 1998b; Meacham et al., 1999; Pind et al., 1994; Yang et al., 
1993; Zhang et al., 2002).  The majority of CFTR mutations, including the ∆F508 mutation, 
result in channel misfolding, highlighting the importance of chaperones in CFTR biogenesis.  
Chaperones dually function to promote the folding of nascent protein chains and, conversely, 
the degradation of mis-folded proteins.  During protein folding, chaperones such as Hsp70 
interact with hydrophobic regions which are generally buried within the native protein.  By 
masking exposed hydrophobic amino acid stretches, chaperone proteins prevent protein 
aggregation and coordinately facilitate proper folding.  In Chinese hamster ovary (CHO) and 
baby hamster kidney (BHK) cells, the overexpression of the human Hsp40 protein, Hdj-1, 
and Hsp70 stabilizes the ER-form of wild-type CFTR, but not ∆F508 CFTR (Farinha et al., 
2002; Meacham et al., 1999; Yang et al., 1993).  Loo et al. demonstrated that, in CHO and 
BHK cells stably expressing wild-type CFTR, treatment with geldanamycin or herbimycin A 
caused Hsp90 to dissociate from nascent CFTR proteins (Loo et al., 1998b).  Furthermore, 
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the loss of Hsp90 binding accelerated the degradation of the ER-form of CFTR via the 
proteasome.  Alternatively, overexpression of CSP with wild-type CFTR in HEK-293 cells 
stabilized and retained CFTR in the ER (Zhang et al., 2002).  Thus, the modulation of 
chaperone levels impacts the folding and ER-exit of CFTR.     
CFTR mutants that fail to achieve a stable conformation are retained in the ER and 
ultimately degraded via the ER-associated degradation pathway (ERAD).  CFTR degradation 
by ERAD depends upon the retention of non-native CFTR in the ER followed by 
proteosomal targeting.  Several mechanisms have been proposed to regulate the ER retention 
of CFTR which include sorting motifs and the glycosylation state of CFTR.  CFTR contains 
four arginine-based RXR motifs which have been shown to function as ER retention signals 
(Chang et al., 1999).  The introduction of arginine to lysine mutations in all four motifs 
(RXR to RXK) in the context of ∆F508 CFTR allowed ~90% of the mutant protein to escape 
the ER.  However, the importance of these motifs for normal CFTR biogenesis is not 
understood.  In addition, the ER resident chaperone calnexin is implicated in the ER-
retention of CFTR (Pind et al., 1994).  Calnexins interact with the N-linked oligosaccharide 
chains of CFTR in a calcium-dependent manner.  The processing of the glycosylation sites of 
native CFTR by glucosidases results in the disassociation of CFTR and calnexin.  However, 
for non-native CFTR, the glycosylation sites are not fully processed, leading to a prolonged 
interaction with calnexin and ER-retention.  Once retained in the ER, chaperones such as 
Hsp70 can recruit ubiquitination machinery including the E2 ubiquitin ligase UbcH5a 
(Younger et al., 2004) and the E3 ubiquin ligase CHIP (Meacham et al., 2001).  The addition 
of a poly-ubiquitin chain targets CFTR for proteosomal degradation (Ward et al., 1995). 
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One caveat to the majority of CFTR-chaperone studies is that these interactions have 
predominantly been studied using heterologous expression systems where CFTR matures 
inefficiently (Ward and Kopito, 1994).  In most heterologous systems, only ~30% of wild-
type CFTR exits the ER.  However, in epithelial cell lines where CFTR is endogenously 
expressed, CFTR is efficiently processed with nearly 100% of newly synthesized protein 
reaching a post-ER compartment (Varga et al., 2004).  The efficient processing of CFTR in 
epithelia, but not other cell types, may reflect lower expression levels in epithelia and/or the 
appropriate complement of chaperones and other regulatory proteins necessary for efficient 
biogenesis.  It will be important in future studies to characterize the interactions between 
CFTR and chaperones in relevant epithelial cells. 
The observation that most disease-causing mutations in CFTR, including the ∆F508 
mutation found in ~70% of CF patients, are retained and degraded in the ER has significantly 
increased the interest in understanding the processes which regulate CFTR biosynthesis.  
Maneuvers such as using chemical chaperones (such as glycerol) or reduced temperatures 
(<30°C) can facilitate the ER-exit of non-native CFTR where to allow its function at the 
plasma membrane, albeit at a lower capacity (Brown et al., 1996; Denning et al., 1992).  
Thus, rescuing non-native CFTR is currently being investigated as an avenue for CF 
therapeutics.  Recently, inhibitors of the calcium-adenosine triphosphate (SERCA) pump, 
such as curcumin and thapsigargin, have received a great deal of attention as they have been 
proposed to increase the export of ∆F508 CFTR from the ER (Egan et al., 2002; Egan et al., 
2004).  Prolonged treatment with SERCA pump inhibitors depletes luminal calcium from the 
ER and presumably causes the disassociation of calnexin from non-native CFTR.  While 
Egan et al. show that curcumin functionally rescues ∆F508 CFTR in cell culture and the 
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∆F508 mouse model; other groups have been unable to validate these findings (Grubb et al., 
2005; Song et al., 2004).   
 Despite the controversies over SERCA pump inhibitors, the rescue of mutant CFTR 
proteins such as ∆F508 is still under investigation as a potential method to treat CF.  
However, recent studies have suggested that this approach is complicated by the fact that 
temperature-rescued ∆F508 CFTR exhibits altered channel gating and decreased stability at 
the cell surface (Clarke et al., 2004; Egan et al., 2002; Egan et al., 2004; Gentzsch et al., 
2004; Swiatecka-Urban et al., 2005a).  Thus, the identification of factors which regulate the 
membrane trafficking and channel activity of CFTR will not only further our understanding 
of normal CFTR physiology, but may provide insights into therapeutic approaches which 
could be useful for augmenting the activity of mutant channels. 
 
Interactions with coat proteins, adaptors, and vesicle fusion machinery regulate CFTR 
membrane trafficking 
The mechanisms which regulate the trafficking of CFTR through the early secretory 
pathway are not well understood.  CFTR, like other ER cargo destined for the Golgi, is 
concentrated at ER exit sites where it is packed into COP-II coated vesicles.  Inhibition of 
COP-II coat assembly by the overexpression of dominant negative Sar1 GTPases causes 
CFTR to accumulate in the ER (Bannykh et al., 2000).  Wang et al. suggested that the 
packaging of CFTR into COPII vesicles in mediated by a direct interaction between a di-
acidic (D-A-D) motif found in CFTR NBD1 with two components of the COP-II coat 
(Sec23/Sec24) (Wang et al., 2004).  The mutation of the second aspartic acid in the di-acidic 
motif to alanine (D567A) blocks the interaction with Sec23/Sec24 and prevents CFTR 
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maturation.  However, these studies do not address whether the defects associated with the 
D567A mutation are specific to the COPII interaction or simply cause a global folding defect 
in CFTR.    
Little is known about the trafficking of CFTR to the Golgi complex following ER 
export.  Studies which follow CFTR maturation often rely on the observation that the core-
glycosylated, ER form of CFTR (band B) migrates with an apparent molecular weight of 160 
kD.  As CFTR is trafficked through the cis and medial Golgi, the N-glycan is processed to a 
complex oligosaccharide, decreasing the electrophoretic mobility to 180 kD (band C) (Cheng 
et al., 1990).  The maturation of wild-type CFTR is not affected by the expression of 
dominant negative Arf1, Rab1a, or Rab2 GTPases, which block conventional ER-to-Golgi 
trafficking (Yoo et al., 2002).  However, the overexpression of syntaxin 13, a target SNARE 
expressed on late endosomes, blocked CFTR maturation.  These data suggest that the 
exocytic trafficking of CFTR follows a non-conventional pathway which involves the sorting 
of CFTR from the ER to the late Golgi or endosomal compartments. 
 In the Golgi, CFTR interact with the PDZ domain-containing protein the “CFTR-
associated ligand” (CAL) (Cheng et al., 2002).  CAL is composed of two N-terminal coiled-
coil repeats followed by a single PDZ domain (these domains are discussed in detail below).  
CAL is broadly expressed across tissues and predominantly localizes to the trans-Golgi 
network (TGN).  Overexpression of CAL reduces the cell surface pool of CFTR by 
decreasing both the half-life of CFTR and the insertion of CFTR into the plasma membrane 
(Cheng et al., 2002).  Subsequent studies have revealed that CAL overexpression targets 
mature CFTR for lysosomal degradation (Cheng et al., 2005).  Furthermore, the expression 
of NHERF-1, a PDZ protein which binds to CFTR at or near the cell surface, restores CFTR 
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surface expression (Cheng et al., 2002).  These data have led to a model whereby PDZ 
proteins “hand-off” CFTR in the Golgi or endosomal compartment to regulate the surface 
expression of CFTR.  However, the importance of CAL in the regulation of CFTR has not 
yet been studied in relevant epithelial cells. 
 The surface expression of CFTR is also regulated by multiple soluble N-
ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) which are 
components of the vesicular fusion machinery.  The V-SNARE syntaxin 1A directly binds 
the N-terminus of CFTR to regulate CFTR trafficking in Xenopus oocytes (Peters et al., 
1999).  Furthermore, this interaction also down regulates CFTR channel activity by reducing 
the open probability of CFTR at the apical cell surface (Naren et al., 2000; Naren et al., 1997; 
Naren et al., 1998).  Syntaxin 1A may also cooperatively regulate CFTR with the t-SNARE 
SNAP-23 (synaptosome-associated protein of 23 kDa) (Cormet-Boyaka et al., 2002).  Like 
syntaxin 1A, SNAP-23 negatively regulates channel gating.  In addition, syntaxin 1a 
potentiates the SNAP-23-CFTR interaction, suggesting that these cognate t-SNARES may 
coordinately regulate CFTR as a heterodimeric complex.  Moreover, the binding of Munc-18 
to syntaxin 1A reverses the inhibitory effect on CFTR open probability, adding another layer 
of complexity to this regulatory interaction (Naren et al., 1997).  Syntaxin 8 may also 
regulate CFTR function by inhibiting channel activity and by decreasing the amount of 
protein on the plasma membrane, but it is unclear whether the protein directly binds CFTR or 
functions in this capacity in polarized epithelial cells (Bilan et al., 2004).  
 Once CFTR reaches the cell surface it is rapidly internalized by clathrin-coated 
vesicles.  The clathrin adaptor AP2 directly binds GST-CFTR C-terminal fusion proteins in 
vitro and mutagenesis studies suggest that the CFTR C-terminus contains multiple tyrosine-
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based internalization motifs (Hu et al., 2001; Weixel and Bradbury, 2000). Once it is cleared 
from the cell surface, CFTR can be rapidly recycled back to the plasma membrane (Gentzsch 
et al., 2004; Picciano et al., 2003). Although the molecular mechanisms are poorly 
understood, especially in polarized cells, a number of proteins including RME1 (Picciano et 
al., 2003), Rab proteins (Gentzsch et al., 2004), myosin VI (Swiatecka-Urban et al., 2004), 
and PDZ proteins (Swiatecka-Urban et al., 2002) have been implicated at various stages of 
the retrieval and recycling process.  As mentioned previously, there is a growing interest in 
the development of therapeutic agents that facilitate the ER-exit of ∆F508 CFTR.  Numerous 
studies have demonstrated that these rescued ∆F508 proteins are trafficked to the cell surface 
and have chloride channel activity (Denning et al., 1992).  However, more recently, several 
studies have shown that resuced ∆F508 is rapidly internalized from the cell surface and 
inefficiently recycled (Gentzsch et al., 2004; Swiatecka-Urban et al., 2005a).  Thus, impaired 
trafficking may complicate ∆F508 rescue as a therapeutic approach.  These observations 
highlight the importance of elucidating the mechanisms which regulate the cell surface 
stability and recycling of CFTR.   
 
Cell surface CFTR is compartmentalized with the cAMP generating machinery and the 
cytoskeleton 
At the apical cell surface, CFTR is compartmentalized with regulatory factors which 
modulate CFTR channel activity.  Our previous work and the results of others are consistent 
with the membrane localization of the cAMP signaling machinery that regulates CFTR.  In 
excised membrane patches, endogenous, membrane-associated PKA activity activates CFTR 
when exogenous cAMP is added in excess, or when membrane associated adenylate cyclase 
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is activated by receptors (Huang et al., 2001; Huang et al., 2000).  Our lab previously used 
small peptides to specifically disrupt protein interactions in Calu-3 cells and further showed 
that PKAII is targeted to the plasma membrane by association with A-kinase anchoring 
proteins (AKAPs) (Huang et al., 2000), one of which may be the cytoskeletal-associated 
protein ezrin (Sun et al., 2000a).  Our lab examined the activation of CFTR by adenosine 
using excised and cell-attached membrane patches from Calu-3 cells.  The addition of 
adenosine to excised membrane patches potently stimulates CFTR channel activity (Huang et 
al., 2001).  These data demonstrate that the adenosine receptor, G-proteins, adenylate 
cyclase, and PKA are all compartmentalized with CFTR within the patch preparations.  
Furthermore, in cell attached patches of Calu-3 cells, the addition of adenosine stimulated 
CFTR activity when it was added to the pipette solution (Huang et al., 2001).  The local 
activation of CFTR by adenosine receptor signaling is mediated by phosphodiesterases 
(PDE), likely a member of the PDE4D family, which form a cAMP diffusion barrier around 
the channel (Barnes et al., 2005).  In a yeast two-hybrid assay, Hallows et al. identified the 
AMP regulated kinase as a direct binding partner of the CFTR C-terminus (Hallows et al., 
2000).  AMP kinases phosphorylate CFTR in vitro and inhibit CFTR-mediated chloride 
conductance in Xenopus oocytes and Calu-3 cells. 
At the apical cell surface, CFTR interacts with the highly related multi-PDZ proteins, 
NHERF-1 (EBP50), NHERF-2 (E3KARP), and NHERF-3 (PDZK1 or CAP-70) (Short et al., 
1998; Sun et al., 2000b; Wang et al., 2000).  Both NHERF-1 and -2 are composed of two 
tandem PDZ domains and a COOH-terminal Ezrin/Radixin/Moesin (ERM) binding domain 
(Reczek et al., 1997).  CFTR binds to the first PDZ domain of NHERFs-1 and -2 which are 
tethered to the actin cytoskeleton via ezrin (Short et al., 1998).  These interactions have been 
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proposed to stabilize CFTR at the apical cell surface.  As such, GFP-CFTR lacking the PDZ 
binding motif exhibits a 60% increase in diffusional mobility compared to wild-type GFP-
CFTR (Haggie et al., 2002; Haggie et al., 2004; Moyer et al., 1999; Moyer et al., 2000).  
Additionally, ezrin can interact with the regulatory subunit of PKA, scaffolding this kinase in 
close proximity to the channel (Sun et al., 2000a).  Naren et al. demonstrated that NHERF-1 
can exist in a macromolecular complex simultaneously with CFTR and the β2 adrenergic 
receptor, an upstream activator of CFTR (Naren et al., 2003).  Furthermore, Wang et al. 
demonstrated that PDZK1, facilitates CFTR dimerization by binding to two channels 
simultaneously, thereby potentiating CFTR activity (Wang et al., 2000).   
More controversial is the role of PDZ proteins in the establishment of the apical 
polarity of CFTR.  Using GFP-tagged CFTR constructs lacking the PDZ binding motif 
(CFTR-∆TRL), Moyer et al. found that CFTR mis-localized to the lateral membranes (Moyer 
et al., 1999).  More recent studies from this group suggest that CFTR is trafficked to the cell 
surface in an unpolarized fashion (Moyer et al., 2000).  However, CFTR is concentrated at 
the apical cell surface via an efficient recycling mechanism which is dependent on binding to 
PDZ proteins.  In contrast, three other groups have found that the apical trafficking and 
retention of CFTR was not dependent upon the PDZ binding motif (Benharouga et al., 2003; 
Milewski et al., 2001; Ostedgaard et al., 2003).  These studies utilized either untagged or 
HA-tagged CFTR-∆TRL expressed in epithelial cells.  One interpretation of these data is that 
the presence of the large N-terminal GFP-tag, in combination with the deletion of the PDZ 
binding motif, contributes to the loss of apical polarity.  However, these studies illustrate that 
the importance of CFTR binding  to PDZ proteins is not fully understood. 
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   Numerous regulatory factors have been identified for CFTR; however, it is not clear 
which ones are relevant in epithelial tissues or how they are organized.  Using biochemical 
and proteomics techniques described in chapter 2, we identified two novel CFTR binding 
proteins, the B’ε subunit of the protein phosphatase PP2A and the cytoskeletal protein 
filamin.  We find that the B’ε subunit interacts with the highly conserved C-terminus of 
CFTR, and this interaction targets a unique PP2A enzyme to CFTR.  Furthermore, our data 
demonstrate that PP2A functionally regulates CFTR in airway epithelia and may be a 
relevant drug target for CF.  In a similar screen, we find that filamins associate with the N-
terminus of CFTR.  The interaction with filamins regulates the cell surface stability and 
endocytic trafficking of CFTR.  Taken together, our research highlights the power of using 
proteomics and mass spectrometry to identify functionally relevant protein-protein 
interactions. 
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Chapter 2:  A single step approach to analyze affinity purified protein complexes by 
mass spectrometry 
 
Introduction 
 The adaptation of mass spectrometry to the study of proteins has provided a powerful 
tool to analyze protein-protein interactions.  In combination with classic biochemical 
approaches such as affinity purification or immunoprecipitation, MS provides a highly 
sensitive and unbiased method to identify the constituents of protein complexes.  This basic 
approach has been extensively applied to studies ranging from the identification of individual 
protein interactions to the characterization of entire interactomes.  However, relevant 
biological samples are often not compatible with MS analysis due to the presence of 
contaminating substances.  These contaminants include salts and detergents, which are 
necessary for biochemical assays, but interfere with protein digestion and the quality of MS 
data (Parker et al., 2005).  In addition, highly abundant proteins can mask and suppress the 
signals of less abundant proteins (Annesley, 2003).  Depending on the method used, 
contaminants include the fusion proteins (such as GST) or antibodies used to purify protein 
complexes in pulldown or immunoprecipitation experiments.  Furthermore, proteins which 
interact with fusion proteins or antibodies non-specifically increase the sample complexity, 
making it more difficult to identify the relevant proteins by MS.   
To minimize sample contaminants, a purification step is often utilized prior to MS 
analysis.  Most commonly, proteins are separated by SDS-PAGE, visualized by coomassie 
blue or other protein stains, excised and digested in-gel.  The combination of SDS-PAGE and 
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in-gel digestion effectively eliminates many contaminants such as salts and detergents, while 
protein contaminants are resolved into discrete bands away from the proteins of interest.  One 
drawback to SDS-PAGE separation is that proteins must be detected by coomassie blue or 
other detection methods, which may not be sensitive enough to detect less abundant proteins 
(Loiselle et al., 2005).  Furthermore, peptide fragments are not fully recovered from the gel, 
often times less than 50%, resulting in lower sequence coverages (Alaiya et al., 2001; 
Oppermann et al., 2000).  Alternatively, proteins or peptides can be purified in-solution using 
additional chromatography steps or dialysis to minimize high concentrations of salts and 
detergents, but not protein contaminants.  Despite their effectiveness to “clean-up” sample 
contaminants, each of these methods results in significant sample loss, which is particularly 
problematic for studying low abundance proteins in the sample.   
In this chapter, we detail the development of a new method to prepare and analyze 
protein complexes by mass spectrometry.  Our goal was to develop a biochemical approach 
to study protein interactions which is MS compatible without requiring additional 
purification steps.  We reasoned that this would allow us to achieve higher quality MS data 
and identify more proteins in our samples.  To accomplish this we designed a procedure 
which allowed us to purify protein complexes while minimizing sample contamination.  The 
combination of our approach with MS analysis provides a powerful means to analyze 
protein-protein interactions.  In the subsequent chapters, we describe the regulation of CFTR 
by novel binding partners which were identified using the methods described here. 
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Experimental Procedures 
Lysate preparation and protein purification 
Mouse kidneys were homogenized in 10 volumes of binding buffer 150 (BB150: 50 
mM Tris pH 7.6, 150mM NaCl, 0.2% CHAPS, 10mM EDTA,  Roche complete protease 
inhibitor cocktail, and 1 mM PMSF) by physical disruption using a tissue homogenizer on 
ice.  Lysates were tumbled at 4°C for 1 hour.  Insoluble material was removed by 
ultracentrifugation at 100,000xg for 1 hour.  Protein concentrations of cell lysates were 
determined by BCA assay (Pierce) and the final protein concentration was adjusted to 1 
mg/ml.  Lysate were pre-cleared of proteins endogenously coupled to biotin by tumbling with 
streptadvidin agarose beads for 1 hour at 4°C at a ratio of 20 µl of settled beads per 1 ml 
lysate.  The beads were removed by centrifugation at 3,000xg for 10min.  Pre-cleared lysates 
were tumbled with the CFTR affinity matrices (20 nmoles of CFTR peptides immobilized to 
100 µl of streptavidin agarose beads) for 4 hours at 4°C.  Lysates were washed 5 times in 10 
mls of BB150 without protease inhibitors for 5 minutes per wash.  As a final wash step to 
remove excess salt and detergent, samples were washed briefly in a low salt buffer (10 mM 
sodium phosphate, pH 7.5 with 75 mM NaCl).  Excess buffer was aspirated using a gel 
loading pipette tip. 
 
Sample elution 
To elute proteins associated with the CFTR affinity matrix, the beads were incubated 
in 1 volume (100µl) of 10% formic acid on ice for 5 minutes.  ddH20 was then added to a 
final volume of 1 ml per sample (adjusting the final concentration of formic acid to 1%).  The 
addition of ddH20 allows for the easy recovery of the supernatant from the beads while 
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decreasing the formic acid concentration so as not to introduce covalent modifications or 
hydrolyze the proteins.  Finally, the beads were pelleted and the supernatant was collected, 
frozen, and lyophilized.   
 
MS Analysis 
The lyophilized samples were processed and analyzed by LC-MS/MS as described 
previously (Borchers et al., 1999).  Briefly, the proteins were reduced, alkylated, and 
digested with modified trypsin.  We analyzed the peptide mixtures using a Waters Q-Tof 
micro, hybrid quadropole orthogonal acceleration time-flight mass spectrometer (Waters, 
Manchester, UK) with a Waters CapLC system configured with a PepMapTM C18 column.  
All data were acquired using Masslynx 4.0 software and then processed using the Proteinlynx 
module.  The processed data was searched against updated NCBInr and Sprot databases 
using Mascot search engine. Mascot probability based Mowse individual ions scores > 46 
were accepted as indicating identity or extensive homology (p<0.05). The MS/MS spectrum 
scores between 20-45 were examined individually with the acceptance criteria being that the 
parent and fragment ion masses were within the calibrated tolerance limits and that the 
spectrum contained an extended series of consecutive y- or b- ions.   
 
Western blot analysis 
Small scale experiments analyzed by western blot were performed similarly to large 
scale experiments with several exceptions.  Lysates were generated from two 100mm dishes 
of Calu-3 cells and CFTR affinity columns were generated with 2 nmoles of CFTR peptide 
and 20 µl of streptavidin agarose.  Bound proteins were resolved by SDS-PAGE and 
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analyzed by western blot using anti-sera generated against NHERF-1 (Affinity bioreagents), 
NHERF-3 (provided by David Silver, Columbia University), Ezrin (Santa Cruz), and Sorting 
nexin 27 (provided by Wanjin Hong, Institute of Molecular and Cell Biology, Republic of 
Korea). 
 
Results 
Our goal was to develop a biochemical approach to study protein interactions which 
is MS compatible without requiring additional purification steps.  To accomplish this, we 
designed a protocol with special attention to lysate preparation, choice of affinity ligand, and 
method of elution which allows us to maximally identify the proteins in our samples without 
further purification.  Our basic approach involves using small, highly purified peptides 
instead of much larger fusion protein or antibodies to capture protein complexes.  In addition, 
we developed a novel elution protocol using formic acid which disassociates protein bound 
to the beads, but does not add further contaminants to the sample.  In this chapter we evaluate 
our method by comparing our results with a sample prepared in parallel, but analyzed by a 
more conventional approach utilizing SDS-PAGE separation and in-gel digestion (Figure 
2.1A).   
To test our method, we took advantage a well-studied protein interaction interface on 
the C-terminus of CFTR.  CFTR is an epithelial specific chloride channel mutated in cystic 
fibrosis.  The extreme C-terminus of CFTR contains a PDZ binding motif which terminates 
in the sequence D-T-R-L (Wang et al., 1998).  Multiple PDZ proteins interact with CFTR to 
compartmentalize CFTR with regulatory factors and the cytoskeleton.  Furthermore, PDZ 
proteins have been suggested to regulate CFTR membrane trafficking ( Moyer et al., 1999). 
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Figure 2.1.  Strategy to purify PDZ proteins associated with CFTR 
A.  Flow chart outlining the techniques used for elution, separation, and MS analysis for 
conventional in-gel approach (top) compared to our in-solution approach (bottom).  B. CFTR 
peptides used in this study.  The peptides correspond to amino acids 1471-1480 of the CFTR 
C-terminus.  To prevent steric hindrance between the peptide and the streptavidin beads, we 
separated the peptide sequence from the biotin moiety by using a serine-glycine-serine-
glycine linker.  C.  Silver-stained gel of proteins which co-purified with wild-type 
CFTR[1471-1480] peptide or the 4G mutant control.  All visible bands were excised, 
digested in-gel with trypsin, and analyzed by MALDI-TOF/TOF MS/MS.  We successfully 
identified proteins from all bands as either NHERF-1 (*) or NHERF-3 (←). 
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Work from our lab and others have described several PDZ proteins which associate with this 
motif including the sodium hydrogen exchange regulatory factor-1 (NHERF-1 or EBP50) 
(Short et al., 1998), NHERF-2 (E3KARP) (Sun et al., 2000b), NHERF-3 (PDZK1, CAP70, 
NaPi CAP-1) (Wang et al., 2000), and the CFTR-associated ligand (CAL) (Cheng et al., 
2002).  Studies of CFTR proteins lacking the PDZ binding motif have suggested that PDZ 
proteins regulate multiple aspects of CFTR biology.  However, it is not clear whether 
additional, unidentified PDZ proteins may be involved in CFTR regulation.  Thus, we sought 
to identify the entire complement of PDZ proteins which associate with the C-terminus of 
CFTR.  To accomplish this, we probed mouse kidney cell lysates with a CFTR peptide 
affinity column and analyzed the bound proteins by LC-MS/MS.  The affinity column was 
generated by coupling biotinylated, synthetic CFTR peptides, corresponding to the last 10 
amino acids of CFTR (CFTR[1471-1480]), to streptavidin agarose beads.  The peptides were 
N-terminally biotinylated which contain a serine-glycine-serine-glycine (SGSG) linker 
region followed by the CFTR sequence with a free C-terminal carboxylate group (Figure 
2.1B).  Control peptides were identical to CFTR[1471-1480] peptides, with the exception 
that the D-T-R-L PDZ binding motif was mutated to glycines (CFTR[1471-1480/4G]).   
To isolate protein associated with the CFTR C-terminus, detergent soluble mouse 
kidney lysates were incubated with either CFTR[1471-1480] or CFTR[1471-1480/4G] 
affinity matrices.  We chose mouse kidney lysates for these studies as they are a rich source 
of epithelia.  The bound proteins were extensively washed, followed by a final wash in a low 
salt buffer.  For our in-solution approach, bound proteins were eluted using formic acid, were 
subsequently diluted, lyophilized, and digested with trypsin in-solution (Figure 2.1A).  We 
specifically chose to use formic acid for the elution because it is strong enough to 
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disassociate proteins bound to the beads and it is volatile and removed from the sample 
during lyophilization.  Following digestion, the peptides were analyzed by LC-MS/MS using 
a Waters Q-Tof micro.  As a comparison, we prepared duplicate samples in which we used a 
more conventional elution and analysis approach.  We chose the following procedures as 
they follow the standard protocol for MS analysis of proteins from acrylamide gels at the 
UNC-Duke Michael Hooker proteomics center, which is similar to many other core 
proteomics facilities.  After incubating the CFTR affinity column with mouse kidney lysates, 
the bound proteins were eluted with Laemmli sample buffer.  The proteins were separated by 
SDS-PAGE electrophoresis and stained with coomassie blue or silver stain (Invitrogen).  All 
visible bands were excised, digested in-gel with trypsin, and analyzed by MALDI-TOF/TOF 
MS/MS as previously described (Parker et al., 2005). 
 By comparison, we identified more proteins with higher sequence coverages using 
our in-solution method versus the conventional in-gel method.  The silver stained, SDS 
PAGE separated sample revealed multiple bands which specifically co-purify with the 
CFTR[1471-1480] peptide, but not the CFTR[1471-1480/4G]  mutant control (Figure 2.1C).  
We successfully identified proteins from all visible bands as either NHERF-1 or NHERF-3, 
both proteins known to associate directly with the CFTR COOH-terminus (Table 1).  While 
we did identify NHERFs-1 and -3, two known direct binding partners of CFTR, by this 
conventional method, we did not identify NHERF-2, a previously identified binding partner.  
Furthermore, we did not identify any indirect or novel binding partners.  We also identified 
NHERF-1 and NHERF-3 by our in-solution method (Table 1).  Moreover, we find NHERF-
2, as well as ezrin, which associates with CFTR indirectly through NHERF-1 and  
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Table 1.  A comparison of proteins identified by in-gel and in-solution approaches 
A summary of the proteins identified by MALDI-TOF/TOF (In-gel approach) and by LC 
MS/MS (In-solution approach).  In addition to achieving higher sequence coverages and 
more confident protein identification, we identified more proteins including indirect and 
novel CFTR binding proteins.   
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Figure 2.2.  The PDZ proteins identified by MS specifically associate with the CFTR C-
terminus 
The affinity pulldown samples were analyzed by western blot using anti-sera generated 
against NHERF-3, NHERF-1, ezrin, and SNX-27.  We find that all of these proteins 
specifically associate with the wild-type CFTR peptide but not the 4G mutant.  These data 
suggest that SNX-27 may be a relevant CFTR binding partner which our lab is currently 
studying. 
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NHERF-2.  Our in-solution method also resulted in the identification of a novel CFTR-
associated protein, sorting nexin 27 (SNX27). Sorting nexins are proteins that regulate 
intracellular trafficking events.  SNX27 contains a PDZ binding motif, a lipid binding PX 
domain, and a putative Ras-association/FERM domain.  While the characterization of the 
CFTR-SNX27 interaction is not described in this dissertation, our data suggest that SNX27 
regulates the endocytic trafficking of CFTR.  We confirmed our MS protein identifications 
by western blot.  Using antibodies specific to NHERF-1, NHERF-3, Ezrin, and SNX-27, we 
find that each of these proteins specifically co-purifies with the CFTR[1471-1480] wild-type 
peptide, but not the CFTR[1471-1480/4G] mutant (Figure 2.2).   
 
Discussion 
Here we describe a procedure which can be used to study protein-protein interactions 
by MS without costly additional purification steps.  Our method relies on using highly 
purified peptides as affinity ligands, a low salt and detergent-free wash, and an acid elution.  
Based on our MS data, our approach significantly improved our ability to identify proteins 
associated with our affinity column. 
The use of peptides in our approach is important for minimizing contaminants in the 
samples.  By comparison, traditional affinity ligands such as GST-fusion proteins or 
antibodies are much larger and generate many more tryptic fragments in the sample.  In 
addition, the small size of the peptides tends to minimize non-specific protein binding.  
Furthermore, peptides from commercial sources can be purchased at >95% purity, thus 
offering a nearly homogenous affinity reagent.  One limitation to using peptides is that they 
may not recapitulate native protein structure and will not likely mimic large globular protein 
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domains.  However, the peptide approach is well suited for studying protein-protein 
interactions associated with the cytosolic tails of transmembrane proteins.  This is 
particularly useful in light of the observations that large transmembrane proteins are 
notoriously difficult to study by MS as they are often endogenously expressed at low levels 
and are only solubilized using high detergent concentrations which may disrupt protein 
interactions.  In addition, this approach could also be used to study other protein interactions 
which involve linear sequences such as the SH3 or WW domains which interact with poly 
proline motifs.   
 While we did not detect any background proteins using the in-gel procedure, we only 
identified two direct binding proteins.  In contrast, we identified more direct binding proteins, 
indirectly associated proteins, and previously uncharacterized binding proteins using the in-
solution approach.  We did detect a single background protein in the sample, propionyl 
coenzyme A carboxylase, co-purified with both the wild-type CFTR[1471-1480] peptide and 
the 4G mutant control.  Propionyl coenzyme A carboxylase (PCC) is endogenously bound to 
biotin and thus, likely associates with the streptavidin beads independently of the peptides 
(Wood and Barden, 1977).  It is also important to note that formic acid elution is stringent 
enough to disassociate the biotinylated CFTR peptides from the streptavidin agarose.  While 
the peptide is separated from larger proteins by SDS-PAGE, the peptide was detected by MS 
using the in-solution method.  However, because of the small size of the peptide (yielding 
only 2 tryptic fragments), the CFTR peptide is sufficiently separated from relevant peptides 
in the sample by HPLC and did not interfere with the MS analysis.    
 Using our approach we identified more proteins and achieved higher sequence 
coverages for all protein identified compared to the in-gel approach.  Furthermore, we 
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identified a novel CFTR binding protein, SNX27.  We predict that SNX27 interacts directly 
with CFTR via its PDZ domain.  However, it may also interact indirectly through NHERFs-
1, -2, or -3 via a PDZ or FERM domain interaction.  Although, we do not describe the 
characterization of the CFTR-SNX27 interaction in this dissertation, we find that SNX-27 is 
highly concentrated in early endosomes where it likely regulates the endocytic sorting and 
recycling of CFTR.  In addition to improving our ability to correctly identify proteins using 
MS data, the high sequence coverages improve the odds for the identification of post-
translational modifications, such as phosphorylation.  Indeed, we identified one phospho-
peptide in our sample corresponding to a serine-phosphorylation at position 285 of NHERF-1 
(data not shown).  Previous studies have demonstrated that NHERF-1 is phosphorylated at 
multiple sites (Fouassier et al., 2005; Reczek et al., 1997).  However, serine 285 has not been 
previously characterized.   
In summary, we describe a novel approach for isolating and characterizing the 
components of protein complexes.  First, the use of peptides as affinity ligands results in 
samples with low background due to proteins binding non-specific, especially compared to 
larger affinity ligands.  Secondly, a brief wash in a low salt buffer helps reduce residual salts 
and detergents.  Finally, the formic acid elution allows the purified proteins to be recovered 
from the affinity matrix, without adding additional contaminants.  Taken together, this 
method provides a highly effective approach to the purification and preparation of samples 
for MS which does not require costly additional purification steps.  
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Chapter 3:  CFTR is regulated by a direct interaction with the protein phosphatase 
PP2A 
 
Introduction 
Cystic Fibrosis (CF) is an autosomal lethal disease characterized by abnormal ion 
transport in epithelial tissues.  CF is caused by mutations in the cystic fibrosis 
transmembrane conductance regulator (CFTR), an apical membrane chloride channel.  The 
regulation of CFTR by the cAMP-dependent protein kinase (PKA) and other protein kinases 
has been extensively documented.  PKA can phosphorylate the CFTR regulatory domain (R 
domain) on at least 11 serine residues (Chang et al., 1993; Cheng et al., 1991; Seibert et al., 
1995). In vivo, PKA phosphorylation increases CFTR open probability and the number of 
channels in the plasma membrane (Ameen et al., 2003; Gadsby and Nairn, 1999).  Work 
from our lab and others have demonstrated that PKA and other regulatory proteins are 
compartmentalized in close proximity to CFTR.  The cellular machinery capable of 
generating cAMP, including the adenosine receptor and membrane bound adenylate cyclase 
are present with CFTR in apical membrane patches (Huang et al., 2001).  A-kinase anchoring 
proteins (AKAPs) target PKA to protein complexes with CFTR (Huang et al., 2000; Sun et 
al., 2000a; Sun et al., 2000b) and the disruption of the PKA/AKAP interaction abolishes the 
ability of PKA to activate CFTR in response to physiologic stimuli (Huang et al., 2000).  In 
addition, the phosphodiesterase PDE4D is also present with CFTR in patch preparations and 
forms a cAMP diffusion barrier at the apical plasma membrane (Barnes et al., 2005).  Other 
CFTR regulatory molecules including protein kinase C (PKC) and the AMP-activated protein 
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kinase (AMPK) are found in protein complexes associated directly with CFTR (Hallows et 
al., 2000; Liedtke et al., 2002).     
Less is known about the ability of serine/threonine phosphatases to regulate CFTR 
activity or how they are compartmentalized with CFTR.  Work from many labs suggests that 
multiple phosphatases including PP2A, PP2B, PP2C, and alkaline phosphatase are involved 
in the deactivation of CFTR (Fischer et al., 1998; Hwang et al., 1993; Luo et al., 1998; 
Reddy and Quinton, 1996; Travis et al., 1997).  In vitro, PP2A and PP2C are most effective 
in dephosphorylating purified CFTR and recombinant R domain.  Furthermore, exogenous 
PP2A and PP2C inactivate CFTR in excised membrane patches (Berger et al., 1993; Luo et 
al., 1998).  In human sweat ducts, cardiac myocytes, 3T3 fibroblasts, and Hi-5 insect cells, 
inhibitors of PP2A increase CFTR channel activity (Berger et al., 1993; Hwang et al., 1993; 
Reddy and Quinton, 1996; Yang et al., 1997).  Likewise, PP2B inhibitors stimulate CFTR in 
NIH 3T3 fibroblasts (Fischer et al., 1998).  However, the contribution of PP2A and PP2B to 
CFTR deactivation may vary in different cell types (Travis et al., 1997; Zhu et al., 1999).  In 
baby hamster kidney cells (BHK), PP2C co-immunoprecipitates with exogenously expressed 
CFTR (Zhu et al., 1999).  Additionally, PP2C overexpression in Fischer rat thyroid cells 
(FRT) decreases CFTR chloride conductance (Travis et al., 1997).  However, the ability of 
endogenous PP2C to regulate CFTR in native epithelial tissues is unclear as no PP2C 
inhibitors have been identified.  To date, no single phosphatase has been demonstrated to be 
both necessary and sufficient to completely down regulate CFTR channel activity, suggesting 
that CFTR is dephosphorylated by multiple phosphatases.   
Here, we present evidence for a direct interaction between CFTR and the 
serine/threonine phosphatase PP2A.  This interaction involves the COOH-terminus of CFTR 
 44
and the PP2A B’ε regulatory subunit.  PP2A localizes to the apical cell surface where it 
negatively regulates CFTR channel activity in Calu-3 cells and intact mouse jejunum.  
Furthermore, inhibition of PP2A increases the airway surface liquid in primary human 
bronchial epithelial cells (HBE) by a mechanism requiring CFTR channel activity.   We 
conclude that PP2A is indeed a relevant CFTR phosphatase in epithelial tissues. 
 
Experimental Procedures 
Cell culture and immunofluorescence  
Calu-3 cells were maintained as described previously (Mohler et al., 1999).  Human 
airway epithelial cells were obtained from freshly excised bronchial specimens from normal 
subjects by protease digestion, seeded directly as primary cultures on 12 mm Transwell Col 
membranes (T-Col; Costar, USA) in modified BEGM medium under ALI conditions, and 
studied when fully differentiated (3-5 weeks). Cultures with transepithelial resistances (Rt) > 
300 Ω cm2 were studied.  Immunofluorescence and confocal microscopy were performed as 
described previously using anti-PP2A subunit antibodies (Kreda et al., 2005).  Monoclonal 
anti-catalytic subunit, monoclonal anti-A regulatory subunit, and polyclonal anti-B’ subunit 
were acquired from Upstate Biotechnology.   
 
Affinity purification of CFTR-interacting proteins  
Peptides corresponding to residues 1375-1401, 1411-1441, 1451-1476, and 1471-
1480 of human CFTR, synthesized with a N-terminal biotin tag (Genemed Synthesis), were 
resuspended in 50 mM Tris-Cl (pH 7.4).  20 nmoles of the peptides were immobilized on 100 
µl of streptavidin agarose (Sigma Aldrich, St Louis, MO) and incubated with Calu-3 cell 
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lysates.  Lysates were prepared by incubating twenty 100 mm dishes of Calu-3 cells in 
binding buffer (50 mM Tris-Cl, 150 mM NaCl, 0.2% CHAPS, and protease (Roche) and 
phosphatase (Sigma Aldrich) inhibitor cocktails) at 4ºC for 1 hour.  Following 
ultracentrifugation, the soluble fraction was pre-cleared over empty streptavidin beads and 
incubated with CFTR peptides conjugated to streptavidin beads for 1 hour.  The bound 
fractions were washed extensively in binding buffer, eluted with 5% formic acid, and 
lyophilized.  Prior to MS analysis, the protein samples were reduced, alkylated, and digested 
with proteomics grade trypsin (Sigma-Aldrich).  The peptides were analyzed by LC-MS/MS 
on a Q-Tof micro (Waters, Manchester, UK).  All data were acquired using Masslynx 4.0 
software and than processed using Proteinlynx module.  The processed data was searched 
against updated NCBInr and Sprot databases using Mascot search engine. Mascot probability 
based Mowse individual ions scores > 46 were accepted as indicating identity or extensive 
homology (p<0.05). The MS/MS spectrum scores between 20-45 were examined 
individually with the acceptance criteria being that the parent and fragment ion masses were 
within the calibrated tolerance limits and that the spectrum contained an extended series of 
consecutive y- or b- ions.  Small scale experiments analyzed by western blot were performed 
using lysates from two 100mm dishes of Calu-3 cells and 2 nmoles of CFTR peptide. 
 
In vitro binding assays  
Binding assays were performed as described previously, with several exceptions 
(Mohler et al., 1999; Scott et al., 2002).  Briefly, the cDNA sequence of the human PP2A B’ε 
subunit was amplified by PCR and cloned into the BamHI and XhoI sites of pET-28C 
(Novagen, Madison, WI).  Recombinant B’ε subunit was produced in either rabbit 
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reticulocyte lysates (Promega, Madison, WI) or in BL21 E. coli (Stratagene, La Jolla, CA).  
For reticulocyte lysates, the PP2A B’ε subunit was purified using Ni-NTA beads (Qiagen) in 
binding buffer (50mM Tris-Cl (pH 7.4), 150 mM NaCl, 0.1% Triton-X 100).  To remove any 
reticulocyte proteins which co-purify with the B’ε subunit, the beads were washed 3X in 
binding buffer plus 2M urea followed by 3 washes in binding buffer.  The B’ε subunit was 
eluted with binding buffer plus 10 mM EDTA.  Bacterial expression of B’ε subunit was 
performed as previously described (Smith et al., 1999).  Purified PP2A core dimer consisting 
of the catalytic and A regulatory subunit were obtained from Promega (Madison, WI). 
Purified proteins were then incubated with indicated CFTR peptides immobilized to 
streptavidin beads in binding buffer plus 0.2% BSA for 1 hour at 4ºC.  Following extensive 
washing, the bound proteins were eluted, resolved by SDS-PAGE, and analyzed by western 
blot or Phosphorimager analysis. 
 
Co-immunoprecipitation and Phosphatase Assays 
Calu-3 cells were scraped into a hypotonic lysis buffer (150mM Tris-Cl, 10mM NaCl, 
and protease inhibitors) and physically disrupted by Dounce homogenization on ice.  The 
lysates were centrifuged at 500xg for 10 minutes to remove nuclei and unbroken cells.  The 
supernatant was subsequently centrifuged at 100,000xg for 1 hour to pellet cell membranes.  
Membranes were resuspended in binding buffer for 1 hour on ice.  CFTR was 
immunoprecipitated using CFTR 596 antibodies (gift of Dr. J. Riordan, University of North 
Carolina at Chapel Hill) or isotype-matched control antibodies covalently conjugated to 
Protein G dynabeads.  Bound proteins were washed extensively and analyzed by western blot 
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using specific antibodies for PP2A subunits or for phosphatase activity using a PP2A 
Immunoprecipitation Phosphatase Assay Kit (Upstate Biotechnology). 
 
CFTR currents in outside-out membrane patches of Calu-3 cells 
The procedures were essentially as described previously (Huang et al., 2001). Briefly, 
CFTR Cl- channel activity was recorded at a membrane potential of 30 mV with a 6-8 
megaohm resistance for an open pipette.   Both the pipette and the bath solutions were the 
same as described previously (Huang et al., 2001).  CFTR channel activity was recorded 
digitally (PClamp software) for 300 seconds following patch excision.  PP2A inhibitors or 
PKI, were included in the pipette solution as indicated.   
 
CFTR currents in mouse jejunum 
Details of this approach have been described previously (Grubb, 1995; Grubb, 2002).  
Briefly, sections of the midportion of mouse jejunum were studied under short circuit current 
(Isc) conditions during a 90 minute recording. A constant voltage pulse (1-5 mV, 1 s 
duration) was applied to the tissue every minute (Physiologic Instruments, San Diego, CA). 
Potential difference (PD) and resistance were calculated by Ohm’s law from the changes in 
Isc in response to the voltage pulse.  Tissues were treated with 100 µM endothall or vehicle. 
 
Confocal microscopy measurement of PCL 
The technique has been described in detail (Tarran et al., 2001).  Briefly, PBS (20 µl) 
containing 2 mg/ml Texas Red-dextran (10 kDa; Molecular Probes, USA) and benzamil (10-4 
M) was added to cultured bronchial epithelium and excess was aspirated to bring PCL height 
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to ~7 µm.  The CFTR-specific inhibitor CFTRinh172 was also included where noted at a 
concentration of 10-5 M. To measure the average height of the PCL, 5 predetermined points, 
one central, four 2 mm from the edge of the culture were XZ scanned as previously described 
(Tarran et al., 2001). For all studies, perfluorocarbon (PFC) was added mucosally to prevent 
evaporation of the PCL and the culture placed on the stage of the confocal microscope over a 
serosal reservoir (80 µl TES-buffered Ringer).  Okadaic acid was added to the apical surface 
as a dry powder in perfluorocarbon (5 µg Okadaic acid/25 ml PFC/cm2 culture). PFC has no 
effect on PCL height or ion transport as previously described (Tarran et al., 2001).  
 
Results 
PP2A physically associates with the COOH-terminus of CFTR 
The COOH-terminus of CFTR mediates protein-protein interactions with PDZ 
proteins (Cheng et al., 2002; Short et al., 1998; Sun et al., 2000b; Wang et al., 2000), the 
adaptor protein AP-2 (Weixel and Bradbury, 2000), and AMP kinase (Hallows et al., 2000) 
to regulate cell surface stability, membrane trafficking, and channel activity.  In the present 
study, we asked whether the highly conserved CFTR COOH-terminus can interact with 
additional proteins that regulate channel function.  We chose to focus on the last 25 amino 
acids of CFTR (encompassing residues 1451-1476) which precede, but do not include, the 
PDZ binding motif.  Previous studies suggest that this region is important for CFTR 
trafficking and channel activity (Ostedgaard et al., 2003); however, no protein interactions 
have been reported.  We immobilized biotinylated CFTR[1451-1476] peptides on 
streptavidin agarose beads, incubated the peptides in cell lysates prepared from a Calu-3 
cells, and eluted the bound proteins with formic acid.  Using nano-LC MS/MS, we identified 
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the serine/threonine protein phosphatase PP2A associated with CFTR[1451-1476].  PP2A 
dephosphorylates CFTR in vitro and decreases channel activity in multiple cell systems 
(Berger et al., 1993; Hwang et al., 1993; Reddy and Quinton, 1996; Yang et al., 1997).  
Recently, Vastiau et al. also identified an interaction between the regulatory domain of 
CFTR and PP2A, suggesting that PP2A anchoring to CFTR may involve multiple contacts 
(Vastiau et al., 2005). 
PP2A is a major cellular phosphatase which regulates many protein targets.  PP2A 
functions as a heterotrimeric complex composed of a catalytic subunit and two regulatory 
subunits, A and B (Janssens and Goris, 2001).  The specificity of PP2A is determined by the 
unique combination of regulatory subunits associated with the catalytic subunit.  The A 
regulatory subunit is encoded by one of two genes α and β which are 86% identical.  The A 
regulatory subunit is tightly associated with the catalytic subunit and functions as a scaffold 
to recruit the B regulatory subunit.  The B regulatory subunit is highly divergent in 
comparison to the other PP2A subunits.  The B regulatory subunit is divided into the B, B’, 
B’’, and B’’’ families which are encoded by at least 14 different genes, some of which 
produce as many as 5 splice variants.  The diversity of regulatory subunits gives rise to over 
75 distinct PP2A enzymes (Figure 3.1).  By mass spectrometry, we observe peptides from all 
three PP2A subunits (Figure 3.2A).  Importantly, the MS/MS spectra provide amino acid 
sequence information which allowed us to precisely identify the PP2A regulatory subunits 
associated with CFTR[1451-1476] as Aα and B’ε (Figure 3.2B). 
By western blot, we confirm that the PP2A catalytic, A regulatory, and B’ regulatory 
subunits associate with CFTR[1451-1476], but not other CFTR C-terminal peptides (Figure 
2.3A).  Furthermore these PP2A subunits also co-precipitate with endogenous CFTR from  
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Figure 3.1.  Diverse subunits give rise to the specificity of PP2A 
PP2A functions as a heterotrimeric complex composed of a catalytic subunit and two 
regulatory subunits (A and B).  The unique combination of regulatory subunits determines 
the substrate specificity and the subcellular localization of the catalytic subunit.  Given the 
number of PP2A subunits identified to date, >75 unique combinations are possible.  
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Figure 3.2.  MS analysis of PP2A subunits associated with the CFTR COOH-terminus 
A. Table of PP2A subunit peptides identified by MS/MS analysis of Calu-3 cell proteins 
associated with CFTR[1451-1476].  B. Example of an MS/MS spectrum used to specifically 
identify the B’ε subunit.  Y ions and corresponding amino acids are labeled on the spectrum. 
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Figure 3.3.  The PP2A heterotrimer co-purifies with CFTR   
A. Biotinylated CFTR peptides were immobilized on streptavidin beads and incubated in 
Calu-3 cell lysates.  Bound proteins were resolved by SDS-PAGE and analyzed by western 
blot using antibodies against the PP2A catalytic, A regulatory, B’ regulatory, and Bα 
regulatory subunits.  B and C. Calu-3 cell lysates were incubated with either anti-CFTR 
monoclonal antibodies or isotype matched mouse IgG covalently coupled to protein G 
dynabeads.  The beads were extensively washed and analyzed by (B) western blot using 
specific PP2A subunit antibodies or (C) assayed for serine/threonine phosphatase activity 
using an Upstate phosphatase assay kit.  To determine the contribution of PP2A to the total 
phosphatase activity, the PP2A inhibitors Okadaic acid or endothall were added during the 
phosphatase assay (n=4 for each condition).  The data represent mean values (n=5) + s.e.m. 
(*p < 0.0005).   
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Calu-3 cell membranes (Figure 3.3B), consistent with an interaction in vivo.  The PP2A Bα 
subunit, which is structurally unrelated to the B’ family, does not co-purify with CFTR[1451-
1476] or co-immunoprecipitate with endogenous CFTR.  In addition, we asked whether 
PP2A phosphatase activity purified with full-length CFTR.  CFTR immunoprecipitates were 
assayed for PP2A using a colorimetric phosphatase assay.  We find that a PP2A-like activity 
specifically co-precipitates with CFTR, but not an IgG control (Figure 3.3C).  Characteristic 
of PP2A, the phosphatase activity was inhibited by 1µM okadaic acid or 1µM endothall, 
potent inhibitors of PP2A (IC50 = 0.1nM and 90nM, respectively). Although okadaic acid and 
endothall can also inhibit PP1(IC50 = 10nM and 5µM, respectively), previous studies have 
found no evidence to support the ability of PP1 to physically associate with CFTR, to 
dephosphorylate CFTR in vitro, or regulate channel activity (Berger et al., 1993; Luo et al., 
1998; Zhu et al., 1999).  Although PP2C has been shown to be associated with CFTR in 
BHK cells, the assay buffer does not contain Mg2+ which is required for PP2C activity.  
Taken, these data suggest that the phosphatase activity associated with CFTR is PP2A.        
 
The PP2A B’ε subunit binds directly to the COOH-terminus of CFTR 
It is clear that multiple phosphatases can regulate CFTR channel activity.  However, 
the degree to which PP2A contributes to this regulation varies in different functional assays 
and cell systems.  Given the diversity of PP2A enzymes, we were intrigued by the possibility 
that the B regulatory subunit may, in part, account for these differences.  Therefore, we asked 
whether the PP2A B’ε subunit could interact directly with CFTR.  We find that PP2A B’ε 
subunit expressed and purified from reticulocyte lysates binds to CFTR[1451-1476], but not 
other CFTR C-terminal peptides (Figure 3.4A).  NHERF-1, previously shown to interact with  
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Figure 3.4.  The B’ε subunit directly interacts with the CFTR C-terminus 
A. The indicated CFTR COOH-terminal peptides were immobilized and incubated with 
radiolabeled B’ε subunit or NHERF-1.  The bound fraction was separated by SDS-PAGE and 
analyzed by phosphorimage analysis.  B.  2 µM CFTR[1411-1441] or CFTR[1451-1476] 
were immobolized and incubated with bacterially expressed B’ε subunit at the indicated 
concentrations.  Bound proteins were washed and analyzed by western blot using a pan-B’ 
antibody.  C. Immobilized CFTR[1411-1441] or CFTR[1451-1476] were incubated with 
purified PP2A core dimer (0.05 U) with or without B’ε (1µg).  Samples were analyzed by 
western blot using PP2A subunit antibodies.   
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the extreme COOH-terminus of CFTR, is enriched by the CFTR[1471-1480] peptide, 
demonstrating the specificity of this assay (Figure 3.4A).  Although we do not find the 
catalytic or A subunit associated with the purified B’ε subunit from reticulocyte lysates (data 
not shown), we cannot rule out that these subunits are present at low levels and may be 
influencing binding to CFTR[1451-1476].  Using bacterially-expressed, purified B’ε subunit 
we observe direct and dose-dependent binding to CFTR[1451-1476] (Figure 3.4B).  
Furthermore, we also find that the core PP2A dimer, composed of the catalytic and A 
regulatory subunit, do not bind to CFTR[1451-1476] unless the B’ε subunit is present (Figure 
3.4C).  While it is not clear if the B’ε subunit alone is necessary and sufficient for targeting 
PP2A to CFTR, these data suggest that the B’ε subunit may play a critical role in the binding 
specificity. 
 
PP2A localizes to the apical cell surface of airway epithelia 
If PP2A is a physiologically relevant CFTR phosphatase, we reasoned that its 
subcellular localization should partially overlap with CFTR.  Given the large number of 
PP2A substrates, we expect the ubiquitously expressed catalytic and tightly coupled A 
regulatory subunits to have a broad cellular distributions.  However, specific B regulatory 
subunits, which target the PP2A enzyme to distinct subcellular compartments, should have a 
more restricted localization.  Using a pan B’ antibody, which recognizes all five gene 
products (α, β, γ, δ, and ε), we examined the localization of PP2A in human airway.  The B’ 
subunits exhibit a broad subcellular distribution in human airway (Figure 3.5).  We find that 
B’ staining strongly localizes to the apical membrane of ciliated cells in superficial epithelia 
and gland ducts, consistent with the localization of CFTR in these tissues.  Although we  
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Figure 3.5.  The PP2A B’ regulatory subunit localizes to the apical compartment of 
ciliated airway cells 
Representative localization of the PP2A B’ regulatory subunit in gland ducts and superficial 
epithelium of the human airway.  Confocal images were acquired in four channels with 
independent laser sources: left, DIC and nuclear staining (DAPI, blue); center actin 
cytoskeleton (rhodamine phalloidin, red); right, PP2A B’ subunit family (green).  
Arrowheads indicate regions of apical staining.  The bottom panel shows IgG controls on 
sections of superficial epithelium (S.E.) and ciliated ducts (C.D.).  Scale bars = 40 µm. 
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cannot unambiguously attribute the apical localization to the B’ε subunit, it is likely that this 
staining reflects the distribution of one or a combination of the cytosolic B’ subunits, B’α, 
B’β, B’δ and B’ε (McCright et al., 1996).  In addition, we observe staining of peri-nuclear 
membranes and nuclear speckles, which is consistent with the observation that the B’γ and 
B’δ localize to the nucleus (McCright et al., 1996; Tarran et al., 2005). 
As we expected, the PP2A catalytic and A regulatory subunits are more broadly 
localized in airway epithelia (data not shown), but clearly localized to the apical cell surface 
of ciliated cells.  The antibodies directed against the catalytic and A regulatory subunits, 
detect both gene products for each subunit.  Thus, these antibodies label every PP2A 
molecule which we expect to give a broad distribution in all cell types.  While the pan B’ 
antibody detects five distinct gene products, this still only represents one out of four families 
of the highly divergent PP2A B regulatory subunit.  Accordingly, the staining pattern for the 
B’ subunit exhibits a more restricted distribution including the sub-apical plasma membrane.   
These localization data support our biochemical evidence for an in vivo interaction between 
CFTR/PP2A.  Furthermore, the PP2A subunits are concentrated at the apical cell surface, 
suggesting a potential role in regulating the channel activity of CFTR at the plasma 
membrane. 
 
PP2A inhibition prevents CFTR rundown in excised patches 
Our previous work and the results of others are consistent with the membrane 
localization of the cAMP signaling machinery that regulates CFTR.  In excised membrane 
patches, endogenous PKA activity activates CFTR when exogenous cAMP is added in 
excess, or when membrane associated adenylate cyclase is activated by receptors (Huang et 
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al., 2001; Huang et al., 2000).  In patch preparations, CFTR channel activity reflects the 
phosphorylation status of the channel which is regulated by a balance between PKA and 
endogenous phosphatases (Berger et al., 1993; Huang et al., 2001; Tabcharani et al., 1991).  
Consequently, CFTR channel gating is increased under conditions in which PKA activity is 
elevated, such as increased cAMP or the inhibition of phosphodiesterases (Barnes et al., 
2005; Cheng et al., 1991).  We hypothesize that “rundown” of CFTR activity following 
excision results from a shift in the balance between endogenous PKA and phosphatase 
activities.  Based on our biochemical analyses demonstrating a physical association between 
CFTR and PP2A, we tested this hypothesis by examining CFTR rundown in excised patches 
under control conditions and in the presence of PP2A inhibitors.  We compared the average 
pipette current during the first 30 seconds of outside out recordings with the average pipette 
current measured from 270 to 300 seconds, as performed in previous studies (Berger et al., 
1991).  Under control conditions, the pipette solution contained ATP and GTP, conditions 
which allow CFTR gating to reflect the activity of endogenous PKA (Huang et al., 2001).  
Furthermore, current flow through the patch is mediated by Cl- traversing CFTR as no 
channel events are observed and pipette current is near zero with protein kinase A inhibitor 
(PKI, 100 nM) in the pipette (0.10±0.10 at 0-30  seconds and 0.00±0.00 at 270-300 seconds, 
n=5 ).  Under these conditions CFTR activity declines variably over 5 minutes (∆I=-
0.66±0.21, n=18) (Figure 3.6A and B).  However, the presence of the PP2A inhibitors 
okadaic acid or endothall in the pipette prevented channel rundown, (∆I=0.51±0.24 and 
∆I=01.81±0.88, respectively, n=10 for each treatment) (Figure 3.6A and B).  Although 
endothall and okadaic acid inhibit PP2A most potently, they can also inhibit other 
phosphatases such as PP1, PP4, and PP5 (Becker et al., 1994; Brewis et al., 1993).   
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Figure 3.6.  PP2A inhibitors functionally regulate CFTR 
Α and B. Basal CFTR currents were measured in apical patches were generated from Calu-3 
cells in the outside-out configuration.  Patches were recorded under control conditions as 
outlined in methods and materials.  Where indicated patches were prepared in the presence of 
okadaic acid (3 nM), endothall (1 µM), and I2PP2A (1.7 µM).  A. Representative traces for 
each condition are shown.  For endothall and I2PP2A, traces were expanded on the X axis to 
clearly show discrete single channel events.  B. Summary of the patch clamp data in Calu-3 
cells.  The ∆Isc for each treatment are compared to ∆Isc = 0 (T-test, P<0.05; + = P<0.05 and 
++ = P<0.005) and compared to ∆Isc of control samples (T-test, P< 0.017; Bonferroni's post-
hoc relative to control, *P < 0.01, **P < 0.001, and ***P < 0.0001).  C. CFTR currents were 
measured in intact mouse jejunum in Ussing chambers as described previously.  Tissues were 
treated with endothall (100 µM) or vehicle for the duration of the recording.   ∆Isc is 
represented as the change in CFTR chloride currents at time 0 versus compared to 90 
minutes.  The data represent mean values (n=4) ± s.e.m. (*p < 0.005).  
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Therefore, we also tested the specific inhibitor I2PP2A, which does not inhibit PP1, PP2B, or 
PP2C (Li et al., 1995a; Li et al., 1996).  Similar to endothall and okadaic acid, I2PP2A 
(1.7µM) also prevented CFTR channel rundown (∆I=1.13±0.85, n=8) (Figure 3.6A and B).   
 
PP2A inhibitors prevents CFTR rundown in an intact epithelium 
Consistent with our observation that CFTR and PP2A physically interact, the effect of 
PP2A inhibitors on CFTR in excised patches suggests that PP2A is present in the patches and 
is, therefore, compartmentalized in close proximity to CFTR.  Furthermore, the inhibitor data 
demonstrate that endogenous PP2A can regulate CFTR channel activity.  These results 
strongly suggest that PP2A functions as a relevant CFTR phosphatase in epithelial tissues.  
We also tested whether PP2A inhibitors altered basal CFTR activity in an intact epithelium.  
We measured basal short-circuit chloride currents in freshly excised sections of mouse 
jejunum in Ussing chamber experiments.  Previous studies demonstrated that CFTR 
constitutes the major chloride channel in these preparations, as jejunum from CFTR -/- mice 
do not exhibit significant chloride conductance (Clarke et al., 1992).  We find that over the 
course of control experiments, basal CFTR activity declined over time (∆Isc = -9.2±2.6, n=4) 
(Figure 3.6C).  In agreement with our patch clamp data, we find that the PP2A inhibitor 
endothall (100µM) prevented rundown of CFTR activity, resulting in increased chloride 
conductance during the course of the 90 minute recording (∆Isc = 12.4±4.9, n=4). 
 
Inhibition of PP2A increases the airway surface liquid height 
Airway epithelial cells regulate the composition of the thin layer of pericilliary liquid 
(PCL) critical for innate host defense.  In CF lung disease, PCL volume is depleted, 
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reflecting an imbalance in solute transport across the epithelium (Guggino, 2001; Knowles 
and Boucher, 2002; Verkman, 2001; Wine, 1999).  Ultimately, PCL depletion results in 
defective mucociliary clearance which supports bacterial colonization and exposes 
individuals to life-threatening infections (Guggino, 2001; Knowles and Boucher, 2002; 
Matsui et al., 1998b; Tarran et al., 2001; Verkman, 2001; Wine, 1999).  Previous studies 
have demonstrated that CFTR mediates the majority of PCL secretion and plays a 
fundamental role in maintaining basal PCL volume (Tarran et al., 2005; Tarran et al., 2002).   
Therefore, we asked whether inhibition of PP2A would increase CFTR activity and thereby 
increase PCL levels in primary human bronchial epithelial (HBE) cultures.  The PCL was 
labeled with fluorescent dextran as previously described (Tarran et al., 2001).  PCL height 
was measured immediately before and 10 minutes after indicated treatments.  Vehicle 
treatment did not significantly change PCL height (Figure 3.7).  However, cultures treated 
with okadaic acid exhibited an ~30% increase in PCL height (∆PCL = +2.61±0.7 µm, n=6) 
(Figure 3.7).  Because PP2A inhibition is likely to influence the activities of many cellular 
proteins, we asked whether CFTR was required for the increase in PCL.  Consistent with 
previous data demonstrating the importance of CFTR in PCL secretion, we find that the 
CFTR inhibitor, CFTRinh172, causes PCL height to decrease by ~30% (∆PCL = -3.21±0.9 µm) 
(Ma et al., 2002).  Furthermore, in the presence of CFTRinh172, okadaic acid was similar to the 
CFTRinh172 alone (∆PCL = -2.3 ± 1.1 µm).  Thus, the inhibition of PP2A with okadaic acid 
increases PCL height by a mechanism which requires CFTR.  These results are consistent 
with our biochemical and electrophysiological studies demonstrating that CFTR is physically 
and functionally associated with PP2A in epithelial tissues. 
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Figure 3.7.  PP2A inhibition increases PCL height in primary human airway cultures 
A. PCL height was assessed in primary cultures of human bronchial epithelia cells treated 
with vehicle (PBS) or okadaic acid (5µg/25ml PFC/cm2 culture) in the presence or absence 
of CFTR inhibitor 172 (10-5M) for 10 minutes.  The PCL was labeled with Texas red dextran 
and the height was measured by confocal microscopy.  Representative images taken at time 0 
or 10 minutes for each condition are shown.  Scale bar = 7 µm. B. Summary of confocal data 
represented as percent change in PCL height at time 0 versus 10 minutes of the indicated 
treatments.  The data represent mean values (n=6 for all conditions with the exception of n=7 
for okadaic acid) ± s.e.m. (Treatments were compared to controls by Mann Whitney U-test, 
*p < 0.02). 
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Discussion 
 
The compartmentalization of signaling machinery with downstream effectors ensures 
the specificity and fidelity of signal transduction in response to extracellular stimuli.  
Previously, we demonstrated that CFTR is localized in close proximity with regulatory 
proteins in vivo including the adenosine receptor, adenylate cyclases, PKA, and 
phosphodiesterases (Barnes et al., 2005; Huang et al., 2001; Huang et al., 2000).  In addition, 
many signaling proteins which regulate CFTR activity, including PKA (Huang et al., 2000; 
Sun et al., 2000a; Sun et al., 2000b), PKC (Liedtke et al., 2002), PP2C (Zhu et al., 1999), and 
AMP kinase (Hallows et al., 2000) have been shown to be organized in multi-protein 
complexes directly associated with CFTR.  The data in the present study add to this model by 
demonstrating that the phosphatase PP2A is both physically and functionally linked to 
CFTR. 
 The regulation of CFTR by phosphatases has been extensively studied.  While it is 
clear from the work of many labs that multiple phosphatases can affect CFTR channel 
activity, the specificity of this regulation is poorly understood.  We identified PP2A in a 
biochemical screen for proteins that associate with residues 1451-1476 of the CFTR COOH-
terminus.  The power of our approach is illustrated by the fact that we unambiguously 
identified the exact PP2A regulatory subunits associated with CFTR by mass spectrometry as 
Aα and B’ε.  To date, at least 21 distinct PP2A regulatory subunits have been identified (2 A 
regulatory and 19 B regulatory subunits) (review in (Janssens and Goris, 2001)).  
Importantly, it is the unique combination of regulatory subunits that governs the enzymatic 
activity, substrate specificity, and localization of PP2A enzymes (McCright et al., 1996; 
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Tehrani et al., 1996).  Thus, the identification of the exact subunits associated with CFTR 
provides insight into the specificity of CFTR channel regulation by phosphatases.   
Using purified proteins, we find that the divergent B’ε subunit interacts directly with 
CFTR[1451-1476] and is required for the binding of the catalytic and A regulatory subunits.  
These data suggest that the B’ε subunit may target the PP2A enzyme to CFTR.  It is 
intriguing to speculate that the expression of the B’ε subunit may account for the differences 
in the ability of PP2A to regulate CFTR channel activity in different cell-types and tissues.  
Many of the CFTR phosphatase studies have utilized heterologous expression systems such 
as Chinese hamster ovary (CHO) cells (Luo et al., 1998), baby hamster kidney (BHK) cells 
(Zhu et al., 1999), and Hi-5 insect cells (Yang et al., 1997), which may or may not express 
relevant CFTR phosphatases and subunits (Luo et al., 1998; Yang et al., 1997; Zhu et al., 
1999).  We are unable to ask whether the PP2A B’ε subunit is expressed in these cell types 
by RT-PCR, as there is insufficient sequence information available at this time.  However, 
the expression of specific PP2A subunits in these cells should be an important consideration 
for future experiments.  Recently, Vastiau et al. reported an interaction between CFTR and 
PP2A, which involves the direct binding of the ubiquitously expressed PP2A Aα regulatory 
subunit to the CFTR regulatory domain (Vastiau et al., 2005).  To demonstrate the specificity 
of the CFTR/Aα interaction, Vastiau et al. show that the over-expressed heat repeats 1-10 
caused a decrease in CFTR rundown, presumably due to the disruption of the Aα/CFTR 
interaction.  However, the PP2A B subunits also bind to heat repeats 1-10 of the A subunit 
and would have been dislodged from the phosphatase complex.  Thus, in these assays the 
observed decrease in CFTR rundown could be attributed to the disruption of the interaction 
between CFTR and both the PP2A A and B regulatory subunits.  Nonetheless, the anchoring 
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of PP2A to CFTR chloride channel may involve multiple sites of interaction mediated by the 
PP2A Aα and B’ε subunits.     
Previous studies have demonstrated a clear role for PP2A in the deactivation or 
rundown of CFTR in native sweat ducts, cardiac myocytes , BHK cells, 3T3 fibroblasts, and 
Hi-5 cells (Berger et al., 1993; Hwang et al., 1993; Reddy and Quinton, 1996; Yang et al., 
1997).  However, the importance of PP2A in CFTR regulation in epithelial tissues seems 
variable.  Thus, we chose to study the physical and functional association of CFTR and PP2A 
in airway epithelia.  Indeed, we find that CFTR and PP2A interact in Calu-3 cells as the 
PP2A catalytic, A regulatory, and B’ regulatory subunits specifically co-precipitate with 
endogenous CFTR (Figure 3.3B).  Additionally, we examined the localization of PP2A 
subunits in human airway.  If in fact PP2A regulates CFTR channel activity in epithelial 
tissues, we would expect the phosphatase to be present at the apical cell surface consistent 
with the localization of CFTR.  The ubiquitously expressed PP2A catalytic subunit and A 
regulatory subunit have a diffuse staining pattern including the apical membrane of the 
superficial epithelium (data not shown).  Alternatively, staining with a pan-B’ regulatory 
subunit antibody shows a more restricted distribution, including strong staining at the apical 
plasma membrane (Figure 3.5).  Thus, the PP2A subunits associated with CFTR are present 
at the apical cell surface where CFTR functions.  Since the available B’ antibodies detect all 
family members, we cannot rule out the possibility that other B’ subunits other than B’ε may 
also associate with CFTR or localize to the apical surface of airway epithelia.  Dozier et al. 
identified an interaction between Chk2 and the PP2A B’γ subunit and found that the other 
highly similar B’ family members, B’α, B’β, B’δ, and B’ε were also able to bind to Chk2 in 
vitro (Dozier et al., 2004).  Consequently, other PP2A B’ regulatory subunits may interact 
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with CFTR.  However, we do not find an association between CFTR and a structurally 
unrelated B regulatory family member, Bα (PR55a) by pulldown (Figure 3.3A) or 
immunoprecipitation (Figure 3.3B).  Thus, the PP2A molecules associated with CFTR at 
least appear to be specific for the B’ family.   
We find that CFTR and PP2A are functionally associated in airway and intestinal 
epithelial cells.  In the presence of PP2A inhibitors, CFTR rundown was blocked in outside-
out membrane patches from Calu-3 cells and intact mouse jejunum (Figure 3.6).  Consistent 
with our biochemical observations, the presence of PP2A in the membrane patches 
containing CFTR strongly suggest that these proteins are closely compartmentalized.  
Furthermore, our data suggest that PP2A is a relevant CFTR phosphatase in epithelial tissues, 
in agreement with Vastiau et al. who find that the addition of okadaic acid in Caco-2 
epithelial cells delayed channel rundown following forskolin treatment (Vastiau et al., 2005).  
In T84 and airway epithelial cells, PP2A inhibitors did not block the rundown of CFTR 
following maximal activation by forskolin (Travis et al., 1997; Zhu et al., 1999). A major 
difference between our data compared to other studies is that we choose to measure the effect 
of PP2A inhibitors on basal CFTR currents as opposed to CFTR currents following maximal 
activation with forskolin or PKA.  It is possible that endogenous PP2A plays a role in 
regulating basal CFTR currents, but that other phosphatases contribute to the deactivation of 
hyper-phosphorylated CFTR.  Future studies are needed to address the relative contribution 
of different phosphatases to the regulation of CFTR channel activity in epithelial tissues.   
In the airways, the mucus layer provides a defensive barrier which traps and clears 
bacteria and noxious particles from the airways (Guggino, 2001; Knowles and Boucher, 
2002; Verkman, 2001; Wine, 1999).  The underlying PCL provides a low viscosity fluid 
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which facilitates ciliary beating and mucus clearance (Gimeno-Alcaniz and Sanz, 2003; 
Hallows et al., 2000; Matsui et al., 1998a).  Based on inhibitor studies, CFTR has been 
demonstrated to play a central role in the maintenance of basal PCL height (Tarran et al., 
2005; Tarran et al., 2002).  Furthermore, the loss of CFTR function results in decreased PCL 
height and increased viscosity.  If in fact PP2A is a relevant CFTR phosphatase in airway 
epithelia, we reasoned that the inhibition of PP2A should increase CFTR chloride 
conductance and ultimately increase PCL height in primary HBE cultures.  We find that the 
inhibition of PP2A by the addition of okadaic acid to primary HBE cultures produces a 30% 
increase in PCL height, consistent with an increase in CFTR activity (Figure 3.7).  
Additionally, when CFTR channel activity is blocked by CFTRinh172, okadaic acid does not 
have a significant effect of the PCL.  Thus, okadaic acid treatment increases PCL height 
through a CFTR dependent mechanism, consistent with our hypothesis that CFTR is 
compartmentalized with and regulated by PP2A in epithelial tissues. 
 In addition to regulating channel activity by dephosphorylating CFTR, PP2A may 
also be important for mediating other signaling and trafficking events for CFTR.  For 
example, AMPK, which directly binds to CFTR and negatively regulates channel activity, 
can also directly interact with PP2A via the A regulatory subunit (Gimeno-Alcaniz and Sanz, 
2003; Hallows et al., 2000).  Moreover, the direct interaction between CFTR and AMPK has 
been mapped to CFTR residues 1420-1457, adjacent to the residues where we observe for 
PP2A, 1451-1476 (Hallows et al., 2000).  It is interesting to speculate that PP2A and AMPK 
may function to stabilize each others interactions with CFTR or may compete for binding to 
the CFTR COOH-terminus.  
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In summary, we establish that CFTR is physically and functionally associated with 
PP2A.  Our data demonstrate that PP2A directly interacts with CFTR via the B’ε regulatory 
subunit.  Furthermore, we provide the first evidence that PP2A regulates CFTR in airway 
epithelia, the major tissue affected in CF.  Finally, we demonstrate that the inhibition of 
PP2A in well differentiated HBE cultures increases PCL height.  Because, decreased PCL 
underlies the basic defect in airway clearance observed in CF patients, our data suggest that 
PP2A may be a useful therapeutic target for CF. 
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Chapter 4:  Filamins regulate the cell surface stability and endocytic sorting of CFTR 
Introduction 
In this chapter, we examine the importance of the 80 amino acid, cytosolic N-
terminus of CFTR.  By engaging in inter- and intra-molecular interactions, the N-terminus of 
CFTR regulates channel biosynthesis, trafficking, and gating.  CFTR proteins lacking the N-
terminus do not exit the ER, demonstrating that the N-terminus is absolutely required for 
normal CFTR biosynthesis (Cormet-Boyaka et al., 2004).  In studies by Zhang et al, the J-
domain containing chaperone, cysteine string protein (CSP), was found to associate with both 
the CFTR N-terminus and R domain (Zhang et al., 2002).  While the physiological 
importance of this interaction is not clear, overexpression of CSPs in Xenopus oocytes and 
HEK-293 cells suggest a role in the ER-retention or folding of CFTR.  In addition, the CFTR 
N-terminus also interacts with multiple soluble N-ethylmaleimide-sensitive factor attachment 
protein receptors (SNAREs) (Cormet-Boyaka et al., 2002; Ganeshan et al., 2003; Naren et 
al., 2000; Naren et al., 1997; Naren et al., 1998).  Naren et al. initially demonstrated that the 
cytosolic domain of syntaxin 1A directly binds to CFTR, thereby reducing the open 
probability of the channel (Naren et al., 1997).  Moreover, the binding of Munc-18 to 
syntaxin 1a reverses the inhibitory effect on CFTR, adding an additional layer of complexity 
to this regulatory interaction.  The t-SNARE SNAP-23 (synaptosome-associated protein of 
23 kDa) also interacts with CFTR and, like syntaxin 1A, SNAP-23 negatively regulates 
channel gating (Cormet-Boyaka et al., 2002).  In addition, syntaxin 1a potentates the SNAP-
23 interaction with CFTR suggesting that these cognate t-SNARES may coordinately 
regulate CFTR as a heterodimeric complex.  Interestingly, an intra-molecular interaction 
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between the CFTR N-terminus and the regulatory domain also regulates channel gating (Fu 
et al., 2001).  Residues 46-63 of the CFTR N-terminus form an alpha helix which interacts 
with the R-domain via several negatively charged amino acids.  Furthermore, disruption of 
this interaction decreases the open probability of CFTR.  It is intriguing to speculate that 
SNARE proteins regulate CFTR gating by competitively inhibiting the N-terminus/R-domain 
interaction.  However, the validity of this model has not yet been tested.  
While the regulation of CFTR by SNARE proteins has predominantly focused on 
CFTR channel activity, SNARE proteinsalso regulate CFTR trafficking.  Using CFTR with 
an extra-cellular epitope-tag, Peters et al. show that overexpression of syntaxin 1a 
specifically decreases the cell surface expression of CFTR (Peters et al., 1999).  More 
recently, syntaxin 8 was also identified as a putative binding partner for the CFTR N-
terminus (Bilan et al., 2004).  In heterologous systems, the over-expression of syntaxin 8 
alters the localization of CFTR from the plasma membrane to the recycling compartment, 
suggesting a role in endocytic trafficking.  Taken together, our current understanding of the 
CFTR N-terminus suggests that this domain interacts with multiple proteins to specifically 
regulate channel biosynthesis, trafficking, and gating.   
The extreme N-terminus of CFTR is highly conserved and is the site of multiple 
disease causing mutations.  However, this region of the N-terminus has not been implicated 
in any regulatory function or interaction.  Using the biochemical approaches described in the 
previous chapters, we specifically asked whether the extreme N-terminus of CFTR is an 
interface for  protein-protein interactions.  Indeed, we find that the CFTR N-terminus directly 
interacts with filamin-A (FLN-A) and filamin-B (FLN-B).  Filamins are classically known to 
function as actin cross-linking proteins.  However, filamins also bind to ion channels, 
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receptors, and soluble signaling proteins and may organize signaling complexes.  In addition, 
filamins regulate cell surface expression, endocytosis, and recycling of a variety of plasma 
membrane proteins including the von Willebrand’s receptor subunit glycoprotein Iba 
(GPIbα) (Feng et al., 2005; Feng et al., 2003; Williamson et al., 2002; Xu et al., 1998), β2- 
and β3-integrins (Glogauer et al., 1998; Loo et al., 1998a; Pfaff et al., 1998; Sharma et al., 
1995), the inward rectifying potassium channel 2.1 (Kir2.1) (Sampson et al., 2003), and the 
hyperpolarization-activated cyclic nucleotide-gated channel 1 (HCN1) (Gravante et al., 
2004).  By studying disease-causing mutations in the CFTR N-terminus, we identified a 
missense mutation, serine 13 to phenylalanine (S13F), disrupts the interaction with filamin.  
In the absence of filamin binding, the surface pool of S13F CFTR is significantly decreased 
and CFTR is prematurely delivered to lysosomes where it is degraded.  Our data highlight a 
previously unrecognized regulatory interaction between filamins and the CFTR N-terminus 
and provide a mechanistic explanation linking the S13F mutation to human disease. 
 
Experimental Procedures 
Plasmids 
 CFTR mammalian expression constructs were prepared in pcDNA3.1(+).  All CFTR 
point mutants used in this study were generated by site directed mutagenesis using the 
QuickChangeXL kit (Stratagene) and sequenced at the UNC DNA sequencing facility.  
Exotope CFTR (herein referred to as HA-CFTR), generated by introducing an HA-tag into a 
modified second extra-cellular loop of CFTR, was provided by Dr. Martina Gentzsch 
(University of North Carolina at Chapel Hill) and described previously (Gentzsch et al., 
2004).  Full-length human FLN-A in the pCMV mammalian expression vector and the 
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bacterial expression constructs used to express GST-FLN-A fusion proteins were provided 
by Dr. Mike Schaller (University of North Carolina at Chapel Hill). 
 
Cell culture 
 Human embryonic kidney cells (HEK-293), HeLa cells, and baby Hamster kidney 
(BHK) cells were cultured in Dulbecco’s Modified Essential Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin.  M2 and A7 
cells, provided by Dr. Gary Thomas (Oregon Health Sciences University), were cultured in 
DMEM supplemented with 2% FBS and 8% normal calf serum (NCS).  BHK cells stably 
expressing HA-CFTR, provided by Dr. Martina Gentzch (University of North Carolina at 
Chapel Hill) was grown in selection media supplemented with 500 µg/ml methotrexate.  
Calu-3 cells were maintained as described previously (Thelin et al., 2005).  Well-
differentiated human primary airway epithelial cells (WD-PAE) were isolated from freshly 
excised bronchial specimens from normal subjects and cultured as described previously 
(Thelin et al., 2005).  Transient transfections were performed using Effectene for HEK-293 
(Qiagen) or Lipofectamine 2000 (Invitrogen) for HeLa and BHK cells.  Assays were carried 
out 24-48 hours post-transfection.  HA-CFTR was expressed in M2 and A7 cells using 
adenovirus, provided by Dr. Wanda O’Neil (University of North Carolina at Chapel Hill), at 
an MOI of 20.  
 
Antibodies and other reagents 
 CFTR monoclonal antibodies 293 and 570 (used for western blots) and CFTR-570 
cross-linked to protein G dynabeads (used for immunoprecipitation) were provided by Dr. 
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Jack Riordan (University of North Carolina at Chapel Hill).  Full-length FLN-A was 
analyzed using monoclonal antibodies 1678 and 1680 (Chemicon), while GST-FLN-A 
truncations were detected using monoclonal anti-GST antibodies (Santa Cruz).  Cell surface 
labeling of HA-CFTR was performed using HA monoclonal antibody HA.11 (Covance).   
 
Affinity purification of CFTR-interacting proteins 
  Peptides corresponding to residues 1-25 of CFTR (wild-type and various mutants) 
were synthesized followed by a serine-glycine-serine-gylcine (SGSG) linker region and a C-
terminal lysine residue coupled to biotin (Tufts University Peptide Core Facility).  Other 
CFTR peptides corresponding to residues 11-35, 27-45, 38-68, and 63-80 of the CFTR N-
terminus contained the SGSG linker and biotin at the N-terminus.  All peptides were 
resuspended in 50 mM Tris-Cl (pH 7.4) and used in affinity purification experiments 
analyzed by mass spectrometry (MS) or western blot as described in Thelin et al (Thelin et 
al., 2005).  Bound proteins were eluted with 100µl CFTR disaggregation buffer (50 mM Tris, 
pH 6.8, with H3PO4, containing 2% SDS, 15% glycerol, 2% β-mercaptoethanol, 1 mM 
EDTA, and 0.02% bromophenol blue (Sarkadi et al., 1992)) and resolved by SDS-PAGE.  
For MS experiments, gels were stained with Coomassie blue per UNC-Duke Michael Hooker 
Proteomics Center standard procedures (http://proteomics.unc.edu).  Visible bands were 
excised and prepared for MS analysis by MALDI TOF/TOF MS/MS previously described 
(Loiselle et al., 2005). 
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Bacterial expression of GST-FLN-A fusion proteins and domain mapping  
 FLN-A fusion proteins including the calponin homology domains and filamin repeats 
1-4, 5-7, 7-11, 12-15, 14-20, 20-23, and 23-24 were expressed in DH5α bacteria as GST-
fusion proteins.  Briefly, 5 mls of overnight culture was inoculated into a 50 ml culture and 
grown at 37 °C for 2 hours.  Isopropyl-beta-D-thiogalactopyranoside (IPTG) was added to a 
final concentration of 100 µM and the bacteria were incubated for an additional hour.  GST-
fusion proteins were purified as described previously (Smith et al., 1999).  All fusion proteins 
were dialyzed into PBS and concentrated using 5,000 MWCO vivaspin columns 
(Vivascience) to a final concentration of 10 µM.     
 The GST-filamin fusion proteins or GST alone were diluted in PBS with 0.1% Triton-
X 100 to a final concentration of 100 nM.  CFTR peptides, CFTR[1-25] or CFTR[S13F], 
were immobilized on streptavidin agarose (1 µg peptide to 20 µls beads) and incubated with 
200 µl of the GST-FLN-A suspensions.  The samples were tumbled at 4 C for 1 hour, washed 
3 times for 5 minutes per wash in PBS with 0.1% Triton-X 100, and eluted with Laemmli 
sample buffer.  Bound proteins were resolved by SDS-PAGE and analyzed by western blot 
using anti-GST antibodies.  
 
Surface plasmon resonance 
 The interaction between the CFTR N-terminus and FLN-A was monitored using 
surface plasmon resonance with a BIAcore3000 (Biacore) at 25°C, with flow rates of 20–25 
µl/min, using Hepes-buffered saline.  Biotinylated CFTR N-terminal peptides (1000–15,000 
response units per peptide) were immobilized on streptavidin sensor chips.  GST-FLN repeats 
1-4, 12-14, or GST alone were injected over the sensor surfaces using injections (KINJECT 
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command) of 20–35 µl, with buffer flowed over the sensor chip to promote dissociation of 
the FLN-A fusion proteins with dissociation times extending to 1000 s.  The FLN-A fusion 
proteins routinely dissociated from each sensor surface completely as judged by the stable 
response unit levels maintained for each flow cell over the course of the experiments.  
Between injections, the chip surface was regenerated by injecting 50 mM NaOH (pH 3.0) 
over the sensor chips.  The signals from a blank flow cell in which no peptide was 
immobilized were used to normalize all sensorgrams.  For kinetic evaluations, sensorgrams 
from each set of titrations were aligned, and the normalized data were globally fit to a 1:1 
binding model (RI = 0) with BIAevaluation 3.2 software (Biacore). Resulting thermodynamic 
constants are the result of three independent sets of titrations. 
 
CFTR immunoprecipitation 
 Co-immunoprecipitation experiments were performed as described in Thelin et al.  
Briefly, CFTR was immunoprecipitated from crude membranes solubilized in binding buffer 
(50mM Tris-Cl, pH 7.4, 150 mM NaCl, 0.1% Triton-X 100) prepared from Calu-3, M1, or 
HEK-293 cells.  CFTR was immunoprecipitated using the CFTR 570 antibody covalently 
bound to protein-G dynabeads.  Bound proteins were washed 4 times for 5 minutes per wash 
in binding buffer.  Bound proteins were eluted with CFTR disaggregation buffer, resolved by 
SDS-PAGE, and analyzed by western blot. 
 
Immunohistochemistry 
 Calu-3 cells were grown on permeable supports and studied after achieving 
transepithelial resistance (Rt) > 300 Ω cm2.  Calu-3 cells were fixed with ice-cold methanol 
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for 2 minutes and blocked for 2 hours in PBS with 2mg/ml BSA, 4% non-fat milk, 1% fish 
gelatin, and 0.1% Triton-X 100 at room temperature.  Primary antibodies (CFTR 570 or 
filamin 1678) were diluted into blocking buffer and incubated on cells overnight at 4°C, 
washed 3 times for 10 minutes per wash in blocking buffer without milk.  Secondary 
antibodies (anti-mouse antibodies conjugated with Alexa-488) were incubated with cultures 
in blocking buffer for 1 hour.  Rhodamine phallodin was included with the secondary 
antibody to label the actin cytoskeleton.  Excess antibodies and phallodin were removed by 
washing 3 times for 10 minutes per wash in PBS.  Transwells were mounted on slides with 
Vectasheild (Vector Laboratories) mounting media.  The preparation of primary WD-PAE 
cultures and frozen sections of human sweat duct were prepared as previously described 
(Kreda et al., 2005).  Confocal microscopy was performed as described previously (Kreda et 
al., 2005).       
 
Pulse-Chase Analysis 
 Wild-type CFTR, S13F CFTR (no interaction with filamins), S13A CFTR (interacts 
with filamins similarly to wild-type), and ∆F508 (folding mutant which does not exit the ER) 
were transiently expressed in HEK-293 cells.  After 24 hours post-transfection, the cells were 
starved in cysteine/methionine free DMEM for 30 minutes.  250 µCi/ml 35S-promix (GE 
Healthcare) was incubated with the cells for an additional 30 minutes.  The labeling media 
was removed and the cells were chased with cold DMEM supplemented with 10% FBS and 
incubated at 37°C for the indicated chase periods.  Cells were recovered by incubating with 
15 mM ice-cold sodium citrate and pelleted by centrifugation.  CFTR was 
immunoprecipitated from whole cell lysates as described above.  Immunoprecipitates were 
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resolved by SDS-PAGE, the gels were dried and imaged by Phosphorimager analysis.  For 
lysosomal inhibitor studies, 10 µg/ml leupeptin was included in the culture media. 
 
CFTR surface labeling and ELISAs 
 Wild-type, S13F, S13A, and ∆F508 HA-CFTR constructs were transiently expressed 
in HeLa or BHK cells grown on glass cover slips (immunofluorescence) or 24-well plates 
(ELISAs).  Cells were fixed with 4% PFA, blocked for 2 hours in blocking buffer (PBS with 
2mg/ml BSA, 4% non-fat milk, and 1% fish gelatin), labeled in anti-HA antibodies in 
blocking buffer for 2 hours, washed 3 times for 10 minutes per wash, and labeled with either 
Alexa-488 (immunofluorescence) or HRP conjutated (ELISAs) secondary antibodies.  
Surface CFTR was analyzed in the absence of detergents, while 0.1% Triton-X 100 was 
added for total CFTR analysis.  For surface ELISAs, labeled cells were incubated with the 
HRP substrate ABTS (Pierce) for 30 minutes at room temperature and analyzed by a 
microplate reader at 405 nm.     
 
Single-particle tracking (SPT) assays 
 SPT experiments were performed collaboratively with Yun Chen and Ken Jacobson 
(University of North Carolina at Chapel Hill).  Anti-biotin IgG gold (BBInternational, UK) 
was dissolved in Ham’s F12 nutrition mixture (Life Technologies/Gibco-BRL) supplemented 
with 25 mM HEPES and 15% serum (HHS), sedimented by centrifugation for 15 min at 
11,000 × g at 4°C and resuspended in HHS. Cells on the cover slips were first incubated with 
biotinylated primary HA antibodies for 10 minutes and washed 3 times with 1 ml of HH per 
wash.  The coverslips were mounted to form an open chamber on the slide with spacers on 
 85
two edges of the coverslip. 100 µl of the solution containing anti-biotin gold was injected 
into the chamber and incubated with cells for 10 minutes at 37°C. Unbound gold particles 
were then washed away by 100 µl of HH.  A final washing step with 100-µl-injected HHS 
was performed to remove unbound gold and the sample chamber was sealed with wax and 
mounted on the microscope; particle trajectories were recorded for the following 30 min at 
37°C, maintained by an air curtain incubator.  
Computer-enhanced video microscopy, described earlier (Lee et al., 1991), was used 
to image colloidal gold bound the plasma membrane. Briefly, the CFTR proteins labeled with 
bound gold were imaged in brightfield mode and recorded with a video camera (Newvicon 
Hamamatsu). After online background subtraction and contrast enhancement with an image 
processing unit (Argus 20, Hamamatsu, Japan), video frames were recorded in time lapse 
mode (1800 frames with 30 frames/s) on the hard disk of a computer (O2, Silicon Graphics, 
Mountain View, CA). Recorded movies were analyzed by the commercial software package 
ISEE (Inovision Corp., Durham, NC) that identifies relative changes of gold particle positions 
on the cell lamella with a precision of ±20 nm. All trajectories were visually inspected to 
ensure correct tracking of gold particles. 
 
CFTR internalization assays 
 To track the internalization of CFTR, HeLa and BHK cells expressing wild-type or 
S13F HA-CFTR were cultured on glass cover slips.  Live cells were chilled to 4°C on ice and 
incubated with HA antibodies diluted in phenol-red and serum free DMEM at a 
concentration of 0.05 µg/µl for 10 minutes.  Unbound antibodies were washed off and the 
cells were returned to 37°C for various times to allow the CFTR/antibody complexes to 
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internalize.  Cells were fixed in 4% PFA, incubated in blocking solution with 0.1% Triton-X 
100, and labeled with Alexa-488 conjugated anti-mouse antibodies.  Lysosomes were labeled 
by incubating cells in 50nM lysotracker red dye (Molecular Probes) for 30 minutes. 
 Peptide transfection 
As an alternative to using the S13F mutation to study CFTR surface expression in the 
absence of filamin binding, we introduced competitive peptides into cells using a cationic 
lipid delivery system.  Specifically, non-biotinylated CFTR[1-25] or CFTR[1-25/S13F] 
peptides were introduced into BHK cells stably expressing HA-CFTR using the Pro-Ject 
cationic lipid delivery system (Pierce).  For each individual well of a 12-well plate, the 
ProJect complexes were formed using 5 µl of ProJect reagent plus 5 µg of CFTR peptide in a 
total volume of 40 µl of Hepes buffered saline (10 mM HEPES, 150 mM NaCl, pH 7.0).  
Since the peptides cannot be visualized, a tracer, Alexa-488 conjugated Fab’ fragments were 
mixed with the peptides at a molar ratio of 4:1 (peptide-to-Fab’ fragment).  The surface 
expression of HA-CFTR was analyzed by immunofluorescence 8 hours after the addition of 
the peptide-lipid complexes as described above. 
  
Results 
The CFTR N-terminus is highly conserved 
To identify additional regions of the CFTR N-terminus important for channel 
function, we compared the sequences of CFTR across species to the analogous region of the 
highly related ABC-transporters, the multi-drug resistance-associated proteins (MRPs).  A 
region encompassing the first 25 amino acids of CFTR shares the highest degree of 
homology with the MRP proteins (Figure 4.4.1A).  Although no functional significance has 
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been assigned to residues 1-25 of CFTR or the MRPs, the amino acid conservation suggests 
an important role for these proteins.  Using the cystic fibrosis mutation database 
(www.genet.sickkids.on.ca/cftr), a repository for CFTR mutations identified in patients with  
clinical symptoms of CF, we identified three missense mutations in amino acids 1-25, proline 
5 to leucine (P5L), serine 13 to phenylalanine (S13F), and tryptophan 19 to cysteine (W19C).  
Strikingly, these mutations occur on CFTR residues which are absolutely conserved across 
species and the MRP proteins.  Although P5L, S13F, and W19C are rare CFTR mutations, 
we speculated that they could provide functional insights into the importance of the extreme 
N-terminus of CFTR.  To that end, we examined the basic molecular defect in CFTR 
biogenesis caused by the P5L, S13F, or W19C mutations.  Each mutation, incorporated into 
the full-length, untagged CFTR protein was transiently expressed in HEK-293 cells.  Wild-
type or mutant CFTR proteins were immunoprecipitated from Triton X-100 soluble 
membranes and analyzed by western blot.  The core-glycosylated, ER form of CFTR (band 
B) migrates with an apparent molecular weight of 160 kD.  As CFTR is trafficked through 
the cis and medial Golgi, the N-glycan is processed to a complex oligosaccharide, decreasing 
the electrophoretic mobility to 180 kD (band C) (Cheng et al., 1990).  Thus, monitoring the 
glycosylation state of CFTR provides as useful method to study CFTR maturation and 
trafficking.  At steady state, wild-type CFTR is predominantly present as the maturely 
glycosylated band C (Figure 4.1B).  Conversely, P5L and W19C are found only as the ER, 
core-glycosylated band B protein (Figure 4.1B).  This is not surprising in light of previous 
observations that missense mutations in many regions of CFTR, including the N-terminus, 
cytosolic loops, nucleotide binding domains, and COOH-terminus disrupt CFTR biosynthesis  
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Figure 4.1. The N-terminus of CFTR is required for normal biogenesis and function 
A.  A primary sequence alignment of N-terminal amino acids of CFTR and MRP proteins.  
B. Wild-type CFTR or the indicated mutants were transiently expressed in HEK-293 cells 
and analyzed by western blot.  C. Wild-type CFTR or the indicated mutants were transiently 
expressed in 16HBE14o-, HEK-293, or HeLa cells and analyzed by western blot.  D. 
Western blot data for CFTR proteins expressed in HEK-293 cells was quantitated using 
densitometry.  For all CFTR proteins, the level of mature band C CFTR was normalized to 
the level of band B CFTR.  Paired t-tests were performed to compare levels of mature CFTR 
protein to wild-type CFTR (** is p<0.005, ** is p<0.0005) or to zero (+ is p<0.01, ++ is 
p<0.001) for an n = 3.  
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and therefore do not exit the ER (Cheng et al., 1990; Seibert et al., 1997; Seibert et al., 1996).  
We were particularly interested in S13F CFTR which clearly exhibits a significant pool of 
mature band C protein.  However, the S13F band B:C ratio is clearly different from wild-type 
CFTR reflecting a 3.6-fold decrease relative to wild-type (Figure 4.1B and C).  In contrast, 
mutation of serine 13 to alanine, S13A, has a band B:C ratio similar to wild-type.  This 
suggests that the decrease in mature CFTR associated with the S13F mutation likely reflects 
the presence of a bulky, hydrophobic phenylalanine residue, as opposed to an absolute 
requirement for a serine at position 13.  We observe similar decreases in the band C protein 
for S13F CFTR in both HeLa cells and an airway epithelial cell line, 16HBE14o-, 
demonstrating that the defect in S13F maturation is not cell type specific and is recapitulated 
in airway epithelial cells where CFTR is expressed (Figure 4.1D).  Thus, the N-terminus can 
play a role in CFTR biogenesis or in the trafficking and stabilization of the mature protein. 
 
The N-terminus of CFTR interacts directly with filamins 
Our mutagenesis studies demonstrate that the extreme N-terminus of CFTR is 
necessary for channel biosynthesis.  Furthermore, the decrease in band C CFTR associated 
with the S13F mutation suggests that the N-terminus may additionally regulate CFTR 
trafficking or protein half-life.  Thus, we speculated that the highly conserved N-terminus 
may mediate a protein-protein interaction which is affected by the S13F mutation.  To test 
this hypothesis, we created CFTR affinity columns using immobilized CFTR peptides 
corresponding to residues 1-25 of the N-terminus, CFTR[1-25].  The CFTR columns were 
incubated with 1 mg of total protein solubilized from Calu-3 airway epithelial cells and 
washed extensively.  Bound proteins were eluted, resolved by SDS-PAGE, and visualized 
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with coomassie blue.  We detected several distinct bands associated with both CFTR[1-25] 
and CFTR[1-25/S13F].  However, two high molecular weight bands (>250 kD) specifically 
and abundantly co-purify with wild-type CFTR[1-25], but not peptides which incorporate the 
S13F mutation, CFTR[1-25/S13F] (Figure 4.2A).  These bands were excised, subjected to in-
gel digestion with trypsin, and analyzed by mass spectrometry (MS).  By MALDI TOF/TOF 
MS/MS, we identified the high molecular weight doublet as human filamin A (FLN-A or 
ABP-280) and filamin B (FLN-B or ABP-278) (Figure 4.2B).  FLN-A and FLN-B are 
composed of two actin binding calponin homology domains, 24 Ig-like filamin repeats, and a 
COOH-terminal dimerization domain (Figure 4.3) (Stossel et al., 2001).  There are three FLN 
genes that share 60-80% sequence identity but differ in the number of FLN repeats and in 
their tissue distribution. FLN-A and -B are broadly expressed while FLN-C is restricted to 
skeletal and heart muscle.  Initially identified as proteins able to cross-link actin filaments to 
form orthogonal networks (Wang and Singer, 1977), filamins are now known to bind ion 
channels, receptors, and soluble signaling molecules, suggesting that filamins can facilitate 
the activation of local signaling events (Table 2).  Additionally, filamins regulate protein 
trafficking, in the biosynthetic and endosomal systems, and helps stabilize ion channels and 
cell surface receptors at the plasma membrane (Table 2).  Filamins have overlapping and 
unique functions and can form homo- or heterodimers, further increasing the complexity of 
FLN-containing protein complexes (Stossel et al., 2001).     
To validate that filamin is a relevant CFTR binding protein, we further characterized 
the interaction in biochemical assays.  In agreement with the MS data, FLN-A co-purifies 
with the CFTR[1-25] peptide from Calu-3 lysates by western blot (Figure 4.4A).  Moreover, 
purified, full-length FLN-A interacts with CFTR[1-25], demonstrating that the interaction is  
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Figure 4.2.  Filamins interact with the N-terminus of CFTR. 
A.  The biotinylated peptides corresponding to residues 1-25 or 1-25 (S13F) of CFTR were 
immobilized on streptavidin agarose and incubated with Calu-3 cell lysates.  Bound proteins 
were resolved by SDS-PAGE and visualized with coomassie blue.  Asterisks indicate the 
bands which were excised and processed for MS analysis.  B. Summary of MALDI-
TOF/TOF MS data used to identify excised bands as filamin-A and filamin-B. 
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Figure 4.3.  Filamins integrate cell signaling and mechanics. 
Filamins are composed of two N-terminal actin binding domains (ABD) and a variable 
number of filamin repeats, the most C-terminal which mediates dimerization (D).  The 
filamin repeats function as protein-protein interaction surfaces that bind to soluble signaling 
molecules, receptors, and ion channels tethering them to the cytoskeleton. 
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Table 2.  Filamins regulates the biosynthesis, trafficking, and activity of numerous 
transmembrane proteins 
Filamins interact with a wide variety of transmembrane proteins including G-protein coupled 
receptors, ion channels, and adhesion receptors.  References: (Arthur et al., 2005; 
Christodoulides et al., 2001; Cranmer et al., 2005; Dubois et al., 2003; Dyson et al., 2003; 
Englund et al., 2001; Enz, 2002; Enz and Croci, 2003; Feng et al., 2005; Feng et al., 2003; 
Glogauer et al., 1998; Gravante et al., 2004; Gu et al., 1999; He et al., 2003; Kanaji et al., 
2002; Kovacsovics and Hartwig, 1996; Li et al., 2000; Loo et al., 1998a; Meyer et al., 1997; 
Nakamura et al., 2005b; Ohta et al., 1991; Onoprishvili et al., 2003; Petrecca et al., 2000; 
Pfaff et al., 1998; Pi et al., 2002; Sampson et al., 2003; Seck et al., 2003; Sharma et al., 1995; 
Takafuta et al., 1998; Tu et al., 2003; Williamson et al., 2002; Xu et al., 1998). 
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Figure 4.4.  The S13F mutation abolishes the interaction between full-length CFTR and 
filamin 
A.  The indicated biotinylated CFTR peptides were immobilized on streptavdin agarose and 
incubated with Calu-3 cell lysates.  Bound proteins were resolved by SDS-PAGE and 
analyzed by western blot using α-FLN-A antibodies.  B Silver stained gel of human FLN-A 
purified from human platelets.  C. The indicated biotinylated CFTR peptides were 
immobilized on streptavdin agarose and incubated purified FLN-A.  D. Purified FLN-A (50 
nM) was incubated with the indicated concentrations of immobilized CFTR peptides.  Bound 
proteins were resolved by SDS-PAGE and analyzed by western blot using α-FLN-A 
antibodies.  E. The indicated biotinylated CFTR peptides were immobilized on streptavdin 
agarose and incubated with Calu-3 cell lysates.  Bound proteins were resolved by SDS-
PAGE and analyzed by western blot using α-FLN-A antibodies. 
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direct (Figure 4.4B and C) and concentration-dependent (Figure 4.4D).  Importantly, the 
incorporation of the S13F mutation abolishes the interaction with FLN-A (Figure 4.4A, B, 
and D).  In addition, using overlapping CFTR peptides that cover the entire N-terminus, we 
find that filamin interacts with both CFTR[1-25] and CFTR[11-35] (Figure 4.4E).  Thus, the  
overlapping sequence, CFTR residues 11-25, defines the filamin binding motif.  Conversely, 
we mapped the CFTR binding site on FLN-A using a series of FLN-A fusion proteins.  
Immobilized CFTR[1-25] or CFTR[1-25/S13F] were incubated with purified FLN-A fusion 
proteins corresponding to the calponin homology domains or filamin repeats 1-4, 5-7, 7-11, 
12-15, 14-20, 20-23, or 23-24.  We find that FLN-A repeats 1-4 bind to the CFTR N-
terminus with the highest affinity (Figure 4.5A).  We used the FLN-A repeats 1-4 protein in 
surface plasmon resonance experiments to determine the affinity of this interaction.  We find 
that FLN-A repeats 1-4 specifically interact with the CFTR[1-25] peptide with a 
disassociation constant of 320 nM (Figure 4.5B).  In preliminary experiments, FLN-B also 
directly associates with CFTR (data not shown).  While our lab is currently characterizing the 
CFTR-FLN-B interactions, the work described here focuses specifically on FLN-A.   
 
CFTR and FLN-A interact in vivo 
 Using in vitro assays, we clearly demonstrate that FLN-A directly interacts with the 
CFTR N-terminus.  Furthermore, the S13F mutation disrupts filamin binding and may 
provide a mechanistic explanation for why the levels of mature S13F CFTR are reduced 
compared to wild-type CFTR.  However, to associate within a biological context, CFTR and 
FLN-A must be co-expressed in the same cells and at least partially co-localize to the same 
subcellular compartment.  Therefore, we examined this interaction in the context of the full-
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length proteins by immunoprecipitation, and asked whether CFTR and FLN-A co-localize in 
relevant tissues.  FLN-A co-immunoprecipitates with endogenous CFTR from Calu-3 cell 
lysates, but not an IgG control (Figure 4.6A).  While these data strongly suggest that CFTR 
and filamin interact in the cell, we cannot rule out that that these proteins associate post-lysis.   
Thus, we performed a mixing experiment to test whether CFTR and filamin must be 
expressed in the same cells to interact by co-immunoprecipitation.  CFTR and human FLN-A 
were expressed in mouse M1 cells as diagrammed in Figure 4.6B.  Taking advantage of a 
FLN-A monoclonal antibody which detects human but not mouse FLN-A, we detect hFLN-A 
in CFTR immunoprecipitates when the proteins were expressed in the same cells (Figure 
4.6C).  However, we do not observe an interaction between CFTR and FLN-A when the 
proteins were expressed independently and mixed post-lysis.  Thus, the CFTR-FLN-A 
interaction takes place in intact cells.   
 We next studied the localization of FLN-A in polarized epithelia known to express 
CFTR.  In polarized Calu-3 cells, FLN-A is associated with intracellular vesicular structures 
and the cell cortex where it is highly concentrated at the sub-apical compartment (Figure 
4.7A).  Likewise, CFTR is observed primarily at the apical cell surface in Calu-3 cells.  We 
observe a similar localization of FLN-A in well differentiated primary airway epithelial cells 
(WD-PAE) and human sweat duct (Figure 4.7B and C).  The strong apical localization of 
FLN-A in polarized epithelia suggest that CFTR and FLN-A may interact at or near the cell 
surface; however, do not preclude an interaction in an intracellular compartment. 
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Figure 4.5.  The N-terminus of CFTR associates with FLN repeats 1-4.   
A.  Filamin domains were expressed as GST fusion proteins and incubated with immobilized 
CFTR peptides.  Bound proteins were resolved by SDS-PAGE and analyzed by western blot 
using a GST antibody.  B, C. Surface plasmon resonance (SPR) was used to determine the 
affinity of the CFTR/FLN interaction.  CFTR[1-25] was immobilized on a streptavidin SPR 
chip and the binding of FLN fusion proteins was analyzed.  B. GST FLN-A repeats 1-4 (10-6 
M), but not GST repeats 12-14 or GST alone, bind to CFTR[1-25].  C. GST FLN repeats 1-4 
interact with CFTR[1-25] with an apparent Kd of 320 nM. 
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Figure 4.6.  FLN-A co-precipitates with endogenous CFTR 
A. Triton-X 100 soluble membranes from Calu-3 cell were incubated with α-CFTR 
monoclonal antibodies covalently bound to protein G dynabeads.  Bound proteins were 
analyzed by western blot using α-CFTR and α-FLN-A monoclonal antibodies.  Inputs 
represent 5% of the total lysates.  B. Schematic of mixing experiment.  Human CFTR was 
expressed in mouse M1 cells.  Human filamin was expressed in the same cells as CFTR (co-
expressed) or in a separated dish of M1 cells (mixed).  For “mixed” samples, lysates prepared 
from cells expressing CFTR alone and human filamin alone were mixed immediately after 
lysis.  C.  The analysis of the mixing experiment.  CFTR was immunoprecipitated from 
lysates and analyzed by western blot using α-CFTR and α-FLN-A monoclonal antibodies. 
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Figure 4.7.  FLN-A localizes to the sub-apical compartment of polarized epithelia   
A and B.  Polarized Calu-3 cells (A) or WD-PAE cells (B) were grown on permeable 
supports and stained with FLN-A or CFTR antisera (shown in green).  No specific staining 
was observed using the secondary antibody alone.  Cell morphology (shown in red) was 
determined using rhodamine phallodin to label actin.  Images are XZ scans from a Leica 
confocal microscope.  C. Frozen sections of human sweat ducts were stained with FLN-A as 
indicated.  Cell morphology was determined using rhodamine phallodin to label actin.  
Images are XY scans from a Leica confocal microscope.  Scale bars = 5 µm. 
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The importance of CFTR residue 13 for FLN binding and CFTR biogenesis 
 We next sought to study the functional significance of the CFTR-filamin interaction 
in cells.  The S13F mutation abolishes filamin binding when incorporated into the CFTR[1-
25] peptide, suggesting that this mutation provides a powerful tool to study FLN-A 
interaction in the context of the full-length channel.  To validate that the S13F mutation 
disrupts filamin binding in a cellular context, wild-type or S13F CFTR were 
immunoprecipitated from transiently transfected HEK-293 cells and analyzed by western 
blot.  While FLN-A clearly co-precipitates with wild-type CFTR, FLN-A is not detected in 
the CFTR/S13F immunoprecipitates (Figure 4.8A). We also compared the effects of 
mutating serine 13 to other amino acids to further understand the importance of amino acid 
charge and size on the CFTR-FLN-A interaction.  For many of the amino acid substitutions 
including S13A, S13N, S13Q, S13D, S13E, and S13H, the band B:C ratio of CFTR is 
indistinguishable from wild-type CFTR (Figure 4.8A).  Furthermore, FLN-A binding is also 
similar to wild-type for these mutants demonstrating that a serine at position 13 is not 
absolutely required for the interaction.  Because S13A CFTR behaves similarly to wild-type 
CFTR with respect to the steady state distribution (Figure 4.1C) and FLN-A binding in both 
peptide pulldowns (Figure 4.4A and 4C) and co-immunoprecipitation experiments (Figure 
4.8A), we have chosen to use it as a control in all other studies.     
By comparison, the substitution of S13 with an acidic amino acid, glutamic or 
aspartic acid, appears to significantly diminish, but not abolish filamin binding.  While it is 
not clear whether S13 can be phosphorylated in vivo, these data suggest a potential 
regulatory mechanism.  Furthermore, the S13I and S13R mutants are only observed in the 
core-glycosylated state indicating that they disrupt folding are not competent to exit the ER.  
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FLN-A binding is not observed for S13I or S13R (Figure 4.8A).  While it is not clear 
whether the S13I and S13R mutations disrupt FLN-A binding, an intriguing possibility is that 
the CFTR-FLN-A interaction takes place in a post-ER compartment.  This prediction is 
further supported by the observation that ER-retained ∆F508 CFTR does not interact with 
FLN.  Furthermore, our immunohistochemistry data suggest that CFTR and FLN-A may 
interact near the cell surface consistent with the accumulation of both proteins near the apical 
membrane in polarized epithelia.  To test this hypothesis, HEK-293 cells were grown at a 
permissive temperature, 28°C, which allow ∆F508 to traffic out of the ER.  Under these 
conditions, we find that ∆F508 CFTR partially matures as indicated by the appearance of 
band C (Figure 4.8B).  By immunoprecipitation, FLN-A co-purifies with rescued ∆F508, but 
not ∆F508 from cells grown at 37ºC.  Thus, we speculate that CFTR and FLN-A may interact 
in a post-ER compartment.  Taken together, these mutagenesis studies further suggest that 
FLN-A interaction is relatively resilient to changes in amino acid size and charge at position 
13 of the CFTR N-terminus.  However, substitutions of S13 to large hydrophobic or highly 
charged residues can decrease the FLN-A interaction with CFTR, as well as affect CFTR 
biogenesis.  Another important finding from these studies is that CFTR and FLN-A likely 
interact in a post-ER compartment.   
  
Filamin binding regulates the turnover of CFTR 
 Our data demonstrate that the N-terminus of CFTR mediates a protein-protein 
interaction with filamins which is disrupted by the disease-causing S13F mutation.  To 
characterize the mechanism underlying the decreased amount of mature CFTR in the band 
B:C ratio observed for S13F, we analyzed CFTR maturation and degradation by pulse-chase 
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over a 24 hour period (Figure 4.9A).  Either wild-type, S13F, or S13A CFTR were 
transiently expressed in HEK-293 cells, labeled for the indicated times, immunoprecipitated, 
and analyzed by autoradiography.  As additional control, we included the ∆F508 CFTR in 
these studies since this mutant represents a biosynthetically defective CFTR protein which 
fails to mature.  After four hours of chase, wild-type and S13A CFTR have almost 
completely matured as indicated by the conversion of band B:C, while ∆F508 exhibits no  
maturation (Figure 4.9A-C).  Furthermore, during the two and four hour time points, S13F  
CFTR does not significantly differ from wild-type and S13A CFTR.  Thus, these data  
suggest that filamins do not regulate CFTR maturation, consistent with our observation that 
CFTR and FLN-A do not likely interact in the ER.  Given that S13F CFTR clearly exits the 
ER, it is unlikely that this mutation causes a global folding defect in CFTR.  Moreover, we 
do not observe a change in the band B:C ratio for S13F CFTR in cells grown at 28°C, 
conditions which permit partial ∆F508 export from the ER (data not shown).  Conversely, 
mature S13F CFTR is significantly less stable than mature wild-type or S13A CFTR during 
the 24 hour chase.  Specifically, the half-life of band C S13F CFTR (t½= 14.1h) is reduced 
by nearly 40% relative to wild-type and S13A (t½= 22.5 h, and 21.6h respectively) (Figure 
4.9A and D).  Thus, the reduction of steady state complex-glycosylated S13F CFTR 
primarily reflects an increase in the turnover of the mature CFTR protein. 
 
Filamins regulate the stability and dynamics of CFTR at the plasma membrane 
We find that the turnover of mature CFTR, rather than CFTR biosynthesis, is most 
significantly affected by the loss of filamin binding.  These results are consistent with 
numerous studies which demonstrate a role for filamin in the regulation of plasma membrane  
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Figure 4.8.  CFTR mutations affect filamin binding 
A.  Serine 13 of CFTR was mutated to additional amino acids.  Wild-type CFTR or the 
indicated mutants were transiently expressed in HEK-293 cells.  CFTR was 
immunoprecipitated from whole cell lysates as described in the experimental procedures.  
Immunoprecipitates were analyzed by western blot using α-CFTR and α-FLN-A antibodies.  
B.  Wild-type, ∆F508, S13F, or S13A CFTR were transiently expressed in HEK-293 cells.  
For rescued ∆F508 (r∆F508), cells were grown at 28°C, conditions which permit the partial 
ER-exit of ∆F508.  CFTR was immunoprecipitated and bound proteins were analyzed by 
western blot using α-CFTR and α-FLN-A monoclonal antibodies. 
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Figure 4.9.  The S13F mutation decreases the half-life of mature CFTR.   
A.  HEK-293 cells expressing wild-type, S13F, S13A, or ∆F508 CFTR were labeled with 
35S-methionine/cystene for 30 minutes and chased with excess cold methionine/cysteine for 
the indicated times.  CFTR was immunoprecipitated, resolved by SDS-PAGE, and visualized 
by autoradiography.  B.  The loss of band B CFTR was tracked at the 0, 2, and 4 hour chase 
times.  The band B CFTR signal from each time point was quantitated and represented as the 
percentage of total CFTR at the zero time point.  C.  CFTR maturation was monitored at the 
0, 2, and 4 hour chase times.  The band C CFTR signal from each time point is represented as 
the percentage of total CFTR at the zero time point.  The data in A, B, and C are 
representative of 4 different experiments.  D.  The half-life of CFTR was calculated by 
following the decrease of band C CFTR during the 4, 16, and 24 hour chase times.  The band 
C CFTR signal from each time point is represented as the percentage of total CFTR at the 4 
hour time point.  We chose the 4 hour time point as it is the earliest time where all labeled 
band B CFTR has been chased to mature band C.  The data summaries results from 4 
different experiments.  The half-life was determined by time in which the total amount of 
CFTR at 4 hours was reduced by 50% (indicated by dashed line). 
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stability of transmembrane proteins.  Because filamins couple directly to actin, they have 
been proposed to anchor their transmembrane binding partners to the cytoskeleton.  
Furthermore, the cell surface expression is significantly decreased for proteins such as GPIβ, 
β1 and β2 integrins, the inward rectifying potassium channel Kir2.1, and the cardiac 
pacemaker channel HCN1 (Table 2) in cells lacking FLN-A.  To examine whether filamins 
regulate the plasma membrane pool of CFTR, we fluorescently labeled cell surface CFTR 
proteins which contain an extracellular HA-epitope (HA-CFTR) in unpermeabilized cells.  
HeLa cells were transiently transfected with either wild-type, S13A, S13F, or ∆F508 HA-
CFTR constructs, fixed in the absence of detergents, and labeled with anti-HA antibodies 
followed by fluorescent secondary antibodies.  We observe significant amounts of wild-type 
and S13A CFTR at the cell surface, while no signal is observed for ∆F508 (Figure 4.10A).  
The lack of ∆F508 CFTR staining reflects intracellular-retention, as reticular staining 
consistent with the ER is clearly observed in cells permeabilized with Triton-X 100.  Unlike 
∆F508 CFTR, we observe surface staining for S13F CFTR; however, the staining is greatly 
reduced compared to wild-type and S13A CFTR.  To quantitatively analyze these 
differences, we used cell surface ELISAs to measure the plasma membrane pool of CFTR 
relative to the total cellular CFTR.  In agreement with our observations by 
immunofluorescence, a substantial pool of wild-type and S13A CFTR localize to the cell 
surface (41.2% and 37.8%, respectively), while almost no ∆F508 is observed (Figure 4.10B).  
Furthermore, the surface pool of S13F CFTR (8.7%) is significantly less than wild-type and 
S13F CFTR; however it is significantly greater than ∆F508.  Thus, in the absence of filamin 
binding, S13F CFTR localizes to the cell surface, albeit at a level 78.8% reduced relative to 
wild-type CFTR. 
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Figure 4.10.  S13F CFTR is expressed on the cell surface, but to a lesser extent than 
wild-type 
HeLa cells expressing the indicated HA-CFTR exotope constructs were fixed in 4% PFA, 
labeled with a mouse anti-HA antibody and a goat anti-mouse secondary antibody conjugated 
with (A) Alexa-488 or (B) horseradish peroxidase.  Surface labeling of CFTR was carried out 
in the absence of detergents, while cells were permeabilized with 0.1% Triton-X 100 for total 
CFTR.  A. Surface or total CFTR was observed by indirect immunofluorescence using a 
Leica confocal microscope.  Scale bars = 10 µm.  B.  The plasma membrane pool of CFTR 
was quantitated by ELISA.  Labeled cells were incubated in ABTS for 30 minutes at 37°C 
and read at 405nm.  Plasma membrane CFTR is expressed as a percentage of total CFTR. 
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 Cytoskeletal interactions regulate the surface expression and spatial organization of 
transmembrane proteins on the plasma membrane.  We previously showed that filamins 
regulate the surface expression of CFTR as the surface levels of the filamin binding mutant, 
S13F, is significantly reduced.  We next used single particle tracking (SPT) experiments to 
further analyze the effects of filamin binding on plasma membrane CFTR.  SPT allows us to 
track the mobility of plasma membrane CFTR in real-time.  Previous studies have used this 
technique to observe the effects of lipid raft compartmentalization, membrane confinement,  
and cytoskeletal anchorage (Kusumi and Sako, 1996; Lambert et al., 2002; Sako et al., 1998; 
Sheets et al., 1997).  Thus, we reasoned that SPT would allow us to observe changes in the 
membrane dynamics of CFTR associated with filamin-mediated cytoskeletal anchorage.  Cell 
surface HA-CFTR proteins were labeled in live HeLa cells using anti-HA antibodies 
followed by colloidal gold-conjugated secondary antibodies.  We then tracked the trajectories 
of single gold particles were measured using computer enhanced video microscopy.  We 
analyzed and compared the trajectories of at least 50 different gold-particles from cells 
expressing wild-type or S13F CFTR.  By SPT, wild-type CFTR diffused randomly across the 
plasma membrane followed by short periods of transient confinement (Figure 4.11A).  On 
average, wild-type CFTR spent 9% of the total recording time in transient confinement zones 
(TCZs) ranging in size from 100-300 nm in diameter (Figure 4.11B).  While the exact nature 
of these confinement zones is not clear, they may represent interactions with the cytoskeleton 
or compartmentalization in lipid rafts.  To determine whether the association with filamins is 
important for the transient confinement of CFTR, we examined S13F CFTR by SPT.  In 
contrast to wild-type, we find that S13F CFTR exhibits significantly less transient 
confinement.  The confinement of S13F CFTR is reduced >50% relative to wild-type, which  
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Figure 4.11.  S13F reduces the plasma membrane confinement of CFTR  
Single particle tracking experiments were performed as described in the experimental 
procedures.  Wild-type or S13F HA-CFTR were transiently expressed in HeLa cells.  Cell 
surface CFTR proteins were labeled with gold particles conjugated to antibodies.  A. An 
example of a 60 second trajectory for wild-type or S13F CFTR.  The entire trajectory is 
shown in blue while statistically defined confinement zones are shown in red.  B. Summary 
of parameters measured during SPT experiments.  Data represent n = 40 for each condition. 
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reflects a decrease in both the number of confinements and the time spent in a single TCZ 
(Figure 4.11A and B).  Interestingly, the diffusion coefficient of wild-type and S13F were not 
greatly different (3.22±0.53 versus 2.22±0.40 10-10cm2/sec), suggesting that, for CFTR, 
incorporation into TCZ does not alter the rate of diffusion in the membrane.  Qualitatively, 
we frequently observed labeled S13F proteins which were not mobile on the cell surface and 
appeared to be engulfed by surrounding membranes.  Because these molecules are not mobile 
they are not included in the SPT analysis.  However, this behavior is consistent with 
internalization.  Taken together our surface labeling and SPT experiments demonstrate that 
filamins modulate both the expression and the confinement of CFTR at the plasma 
membrane.  Furthermore, these data support the hypothesis that filamins play a role in the 
cell surface stability and spatial organization of CFTR on the cell surface by coupling the 
channel to the actin cytoskeleton.     
 
S13F CFTR is prematurely targeted to lysosomes 
 In addition to regulating the stability of cell surface proteins at the plasma membrane, 
filamins are key regulators of endosomal trafficking.  In cells lacking FLN-A, the normal 
sorting pathways of proteins such as furin (Liu et al., 1997), PSMA (Anilkumar et al., 2003), 
and the calcitonin receptor (Seck et al., 2003) are altered, resulting in the mis-localization of 
these proteins to various endosomal compartments.  At the plasma membrane, CFTR is 
rapidly internalized into clathrin-coated vesicles and efficiently returned to the cell surface 
via endocytic recycling (Bradbury et al., 1999; Bradbury et al., 1994; Lukacs et al., 1997; 
Peter et al., 2002; Prince et al., 1999; Prince et al., 1994).  If the normal recycling of CFTR 
was impaired in the absence of filamin binding, we predict that this would account for the 
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decreased cell surface levels.  To that end, we followed the endocytic trafficking of 
internalized CFTR proteins.  HeLa cells transiently expressing either wild-type or S13F HA-
CFTR were chilled to 4°C to block internalization and labeled with anti-HA antibodies.  
After removing excess antibodies, the cells were warmed to 37°C for 2, 4, or 8 hours after 
which the cells were fixed, permeabilized and labeled with fluorescent secondary antibodies.  
Using the same HA-CFTR construct stably expressed in BHK cells, Gentzsch et al. found 
that internalized CFTR is predominantly localized to early endosomes by 1 to 2 hours, late 
endosomes by 4 hours, the TGN by 20 hours, and lysosomes by 24 hours (Gentzsch et al., 
2004).  In our experiments both wild-type and S13F CFTR exhibit partial overlap with the 
early endosome marker EEA1 and internalized transferrin at the 2 hour time point (data not 
shown).  However, we observe the most striking difference between wild-type and S13F 
CFTR at the later 4 and 8 hour time points (Figure 4.12A).  At both 4 and 8 hours, we 
observe a combination of cell surface and vesicular staining for wild-type CFTR.  Consistent 
with the findings of Gentzsch et al, we observe no co-localization of wild-type CFTR with 
lysosomes by 8 hours (Gentzsch et al., 2004).  In contrast, we see a stronger punctuate 
pattern for S13F CFTR at 4 and 8 hours, with no visible surface staining.  Furthermore, at 8 
hours, the distribution of S13F CFTR exhibits significant overlap with lysosomes labeled 
with lysotracker red (Figure 4.12A).  Thus, these data suggest that filamins play a role in the 
endocytic recycling of CFTR.   
 In our initial studies of the CFTR N-terminal mutations, we found that the steady-
state distribution of S13F CFTR displays a decrease in the mature band C protein, which 
reflects increased degradation.  Additionally, S13F is prematurely sorted to lysosomes, which 
may explain why mature S13F CFTR is degraded more rapidly than the wild-type protein.  
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Therefore, we examined the half-life of wild-type, S13F, or S13A CFTR by pulse chase in 
the presence of the lysosomal protease inhibitor leupeptin.  Strikingly, leupeptin significantly 
increased the half-life of S13F CFTR from 13.4 hours to 18.3 hours (Figure 4.12B).  
Although leupeptin did not fully rescue S13F to the half-life of wild-type CFTR (t1/2 = 21.9 
hours), it suggests that lysosomal mediated degradation accounts for the majority of S13F 
turnover. 
The S13F defects reflect the loss of filamin binding 
 Our data suggest that filamin binding affects the cell surface stability, endocytic 
trafficking, and half-life of mature CFTR.  However, we were concerned that some of the 
defects observed for S13F CFTR may be independent of filamin binding.  To address this 
issue, we asked whether we could recapitulate the decrease in CFTR surface expression by 
using other means to abolish the CFTR-filamin interaction.  First, we took advantage of a 
well characterized melanoma cell line which lacks endogenous FLN-A (M2) and a paired 
cell line stably re-expressing FLN-A (A7).  By immunofluorescence, we clearly observe a 
decrease in the cell surface pool of CFTR in the FLN-A null M2 cells compared to the A7 
cells (Figure 4.13A).  Again, using the cell surface ELISA, we find that the percent of CFTR 
on the cell surface is reduced by 67% in the M2 cells relative to the A7 cells (Figure 4.13B).  
This decrease is not as statistically significant as the 80% reduction of cell surface levels 
observed for S13F CFTR compared to wild-type CFTR.  However, we speculate that wild-
type CFTR can interact with FLN-B in M2 cells while S13F CFTR reflects a loss of binding 
to both FLN-A and FLN-B.  In peptide pulldown experiments using M2 and A7 cells, we 
isolated high molecular weight bands with the CFTR[1-25] peptide which were absent with 
the CFTR[1-25/S13F] peptide (data not shown).  By MS, we identified these bands as FLN- 
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Figure 4.12.  S13F is prematurely trafficked to lysosomes where it is degraded 
A. Wild-type or S13F HA-CFTR were transiently expressed in HeLa cells.  The cells were 
chilled to 4°C on ice, incubated with α-HA antibodies, washed extensively, and  were then 
re-warmed for the indicated chase times.  The cells were subsequently fixed with 4% PFA, 
permeabilized with 0.1% Triton-X 100, and internalized CFTR was labeled with Alexa-488 
anti-mouse antibodies.  To label lysosomes, lysotracker red (50 nM) was incubated with the 
cells for 1 hour prior to fixation.  CFTR was observed by indirect immunofluorescence using 
a Leica confocal microscope.  B. HEK-293 cells expressing wild-type or S13F CFTR were 
labeled with 35S-methionine/cystene for 30 minutes and chased with excess cold 
methionine/cysteine for the indicated times in the presence or absence of the lysosomal 
inhibitor leupeptin (10 µg/ml).  CFTR was immunoprecipitated, resolved by SDS-PAGE, and 
visualized by autoradiography.  C. The half-life of CFTR was calculated by following the 
decrease of band C CFTR during the 4, 12, and 24 hour chase times.  The data summaries 
results from 3 different experiments.  The half-life was determined by time in which the total 
amount of CFTR at 4 hours was reduced by 50% (indicated by dashed line). 
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Figure 4.13.  CFTR surface expression is reduced in cells lacking FLN-A   
A. HA-CFTR was expressed using adenovirus in FLN-A null M2 cells or FLN-A re-
expressing A7 cells.  The cell surface pool of CFTR was examine by indirect 
immunofluorescence (A) or surface ELISA (B) as described previously.  For ELISAs, GFP 
adenovirus infected cells were used as a negative control. 
 
 127
 128
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14.  Competitive peptides decrease CFTR surface expression 
CFTR[1-25] or CFTR[1-25/S13F] peptides were introduced into BHK cells which stably 
express HA-CFTR using the ProJect cationic lipid delivery system.  Because the peptides 
cannot be visualized, fluorescently labeled Fab’ fragment was mixed with the peptides prior 
to transfection.  Cell surface CFTR was labeled with fluorescent antibodies in 
unpermeabilized cells 8 hours post-transfection.  Total CFTR was also examined in 0.1% 
Triton-X 100 permeabilized cells to ensure that the CFTR[1-25] peptide did not affect CFTR 
expression.  The cells were imaged using a Zeiss fluorescent microscope. Scale bars = 5 µm. 
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A and FLN-B from A7 cells, however, only FLN-B was identified from the M2 cells. This 
result was confirmed by western blot using FLN-A antibodies (data not shown).  In 
summary, we observe a decrease in the plasma membrane pool of CFTR in FLN-A null cells, 
which is consistent with our observations for S13F CFTR.   
In a second approach, we used a cationic lipid transfection system to introduce CFTR 
peptides into cells to disrupt the CFTR-Filamin interaction in situ.  Using this approach, we  
successfully delivered several fluorescent probes into cells such as FITC-labeled antibodies, 
Fab’ fragments, and streptavidin.  While these probes appeared to be abundantly delivered to 
cells, the number of transfected cells was low (~10%).  The low transfection efficiency 
precludes using assays such as a cell surface ELISA.  Therefore, we chose to analyze the 
effects of the peptide transfection using single cell assays.  We examined the surface 
expression of CFTR in BHK cells stably expressing exotope CFTR and transfected with the 
non-biotinylated CFTR[1-25] peptide co-transfected with FITC-labeled Fab’ fragments as a 
tracer.  Unlike the untransfected cells, we find that the transfected cells exhibit little to no 
CFTR surface expression (Figure 4.14A).  Importantly, this effect was not observed when the 
S13F peptide or the tracer alone were transfected.  Thus, using several different approaches 
to manipulate the CFTR-filamin interaction, we consistently find that filamin binding is 
required for the normal surface expression of CFTR.  These data strongly support our 
hypothesis that the defects associated with the S13F mutation reflect a loss of filamin binding 
and provides a mechanistic explanation for why this missense mutation causes cystic fibrosis.   
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Discussion 
Filamins are structural proteins which regulate cellular organization.  Composed of 
two N-terminal actin binding domains and 24 Ig-like filamin repeats (the most C-terminal 
which mediates dimerization), filamin dimers are able to crosslink actin filaments (Gorlin et 
al., 1990).  Filamins were originally identified as gelation factors capable of organizing 
orthogonal actin networks critical for structures such as the cell cortex (Glogauer et al., 1998; 
Wang and Singer, 1977).  Filamins are now known to bind to more than 30 different proteins 
ranging from ion channels, matrix receptors, G-protein coupled receptors, and soluble 
signaling molecules (Stossel et al., 2001).  Like their role in cytoskeletal organization, 
filamins generally regulate structural and organizational aspects of their binding proteins.  
Based largely on studies using the FLN-A null M2 cells and the FLN-A re-expressing A7 
cells, investigators have suggested that the association with filamins modulates the plasma 
membrane expression, endocytic trafficking, and protein complex formation for numerous 
cell surface proteins.  We find that filamins associate with the highly conserved N-terminus 
of CFTR and that the disease-causing missense mutation in CFTR, S13F, abolishes the 
interaction (Figure 4.4).  Consistently, we find that in the absence of filamin binding, the cell 
surface expression (Figures 4.10, 4.13, and 4.14), endocytic trafficking (Figure 4.12), and 
half-life of CFTR (Figure 4.9) is impaired.  Thus, filamins regulate multiple aspects of CFTR 
biology.   
Thus far, we have studied the function of the CFTR-filamin interaction using over-
expression systems including HEK-293, HeLa, and BHK cells.  The ability to transiently 
transfect these cells make them a convenient model system for initial studies.  While 
heterologous systems are commonly used to study CFTR, they may not accurately reflect the 
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regulation of CFTR in epithelial tissues.  Therefore, in future studies it will be critical to 
examine the CFTR-filamin interaction in relevant cell types such as airway epithelial cell 
models including WD-PAE, 16HBE14o-, and Calu-3 cells; as well as intestinal epithelial 
models such as T84 and Caco-2 cells.  Importantly, we have already shown that the pool of 
mature S13F CFTR is decreased in 16HBE14o- cells similar to our findings in fibroblasts 
(Figure 4.1C).  Thus, we expect that the interaction with filamins will be important for CFTR 
in epithelial cells.  We are currently generating reagents such as adenovirus and retrovirus, 
which will be used to express CFTR proteins in epithelia.  Since filamins are so critical to the 
maintenance of the actin cytoskeleton, we rationalized that disrupting the normal function of 
FLN-A or FLN-B would severely impair epithelial cell polarity.  Thus, we will take 
advantage of our observation that the S13F mutation disrupts filamin binding to study the 
functional significance of this interaction in epithelial cells.  
However, while it is attractive to attribute defects such as plasma membrane stability 
and impaired endocytic sorting to the lack of filamin binding, it is possible that the S13F 
mutation causes additional phenotypes independent of filamin.  Benharouga et al. reported 
that CFTR lacking the last 70 amino acids (∆70 CFTR) is normally trafficked to the cell 
surface (Benharouga et al., 2001; Haardt et al., 1999).  However, ∆70 CFTR is not stable and 
is thereby ubiquitinated and degraded via the proteasome.  The net effect of the ∆70 CFTR 
defect is that this protein displays nearly normal maturation and increased degradation of the 
mature protein.  It is possible that mature S13F CFTR, like ∆70 CFTR, degraded more 
rapidly because it results in CFTR mis-folding which destabilizes the protein.  Our data argue 
that this is not the case and that S13F CFTR is functionally distinct from ∆70 CFTR based on 
several lines of evidence.  First, maneuvers which rescue CFTR defects, such as growing 
 133
cells at reduced temperatures, do not increase the mature pool of S13F, but do rescue ∆70 
CFTR (data not shown).  In addition, ∆70 CFTR is more heavily ubiquitinated than wild-type 
CFTR (Benharouga et al., 2001).  Conversely, we do not find any difference between the 
ubiquitination status of S13F and wild-type CFTR (data not shown).  Furthermore, the 
decreased surface expression of S13F CFTR is recapitulated by introducing competitive 
peptides into cells expressing wild-type CFTR or by expressing wild-type CFTR in the FLN-
A null M2 cells (Figure 4.13).  The cell surface defects observed for the S13F CFTR are 
more severe than wild-type CFTR expressed in M2 cells (4-fold versus 3-fold reduction in 
surface expression).  However, S13F CFTR reflects a loss of FLN-A and FLN-B binding 
(Figure 4.4), while M2 cells express FLN-B which also interacts with CFTR.  Thus, it is 
likely that FLN-B is also a relevant CFTR interacting protein (discussed in greater detail in 
Chapter 5).  Finally, the introduction of competitive CFTR NH2-peptides into cells disrupts 
the cell surface expression of CFTR (Figure 4.14).  This effect is specific to the wild-type 
peptide as the S13F peptide has no effect in this assay.  Altogether, our data strongly argue 
that the S13F defects are specific to the loss of filamin binding.   
In future experiments, we will utilize additional mutations in CFTR residues 11-25 to 
study the interaction with filamins.  The identification of additional CFTR mutations which 
disrupt filamin binding will further validate the link between the S13F phenotypes and CFTR 
regulation by filamins, as well as, provide valuable information regarding the nature of this 
interaction.  The recent crystal structure of GPIbα C-terminus and repeat 17 of FLN-A 
provides important insights into the CFTR/filamin interaction which will use to design other 
CFTR mutants incapable of interacting with filamins (Nakamura et al., 2005b).  FLN repeats 
are composed of an Ig-like β-sandwich fold.  In the crystal structure, residues 562-572 of the  
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Figure 4.15.  The filamin binding motif of CFTR is similar to other filamin binding 
proteins 
Primary sequence alignment of the filamin binding motif of CFTR, GPIbα, and the β7-
integrin.  Identical amino acids are shown in black while conserved amino acids are shown in 
gray.  The arrow indicates the experimentally determined β-sheet structure for GPIbα which 
is predicted for CFTR based on multiple secondary structure predictions (analyzed using 
PELE at http://workbench.sdsc.edu). 
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GPIbα COOH-terminus adopt a β-sheet conformation when inserted between beta sheets C 
and D of FLN-A repeat 17.  This interaction relies most heavily on a stretch of hydrophobic 
residues in GPIbα which make contacts with the filamin repeat.  A bioinformatics analysis of 
the CFTR NH2-terminus reveals that residues 11-21 are predicted to form a β-sheet.  
Furthermore, there are several residues conserved between CFTR and GPIbα which are 
critical for the GPIbα/FLN-A interaction (Figure 4.15).  These include several large 
hydrophobic residues, as well as, a proline which terminates the β-sheet.  Similarly, the 
filamin binding domain of the β2-integrin C-terminus also shares this β-sheet confirmation  
and spacing of hydrophobic residues.  Amino acid differences in the filamin binding domains 
of CFTR, GPIbα, and β7-intergrins, likely account for their preferences for different filamin 
repeats.  However, the overall similarities suggest a common mode of binding.  We predict 
that mutating the other residues in this putative β-sheet in the CFTR N-terminus, such as 
L15, F16, F17, S18, and W19 may also disrupt the CFTR/filamin interaction.  Tryptophan 19 
is also highly conserved in the CFTR and NH2-terminus and the mutation to cysteine 
(W19C) is associated with human disease.  We find that the W19C is a folding mutant which 
does not exit the ER.  However, in peptide binding experiments W19C interacts with filamin 
(Figure 4.1 and data not shown), although it is not clear whether the binding affinity is 
altered.  In future studies, we will take advantage of this structural information to design 
additional CFTR mutations to further characterize the interaction with filamins. 
We are excited to continue our studies of the CFTR-filamin interaction in epithelial 
cells as our lab has had a long-standing interest in understanding how CFTR and other ion 
channels are regulated by cytoskeletal attachments and the compartmentalization with 
regulatory factors.  Work from our lab and others have shown that PDZ proteins, like 
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filamins, serve as scaffolds to organize membrane proteins into regulatory complexes with 
signaling molecules and the cytoskeleton.  The association of CFTR with plasma membrane 
PDZ proteins may serve multiple functions in polarized cells; these functions likely differ 
based on the cell type and the specific constellation of PDZ proteins and their binding 
partners that are expressed.  From studies examining CFTR proteins lacking the final three 
amino acids (CFTR/∆TRL), investigators have suggested that the association with PDZ 
proteins modulates CFTR surface expression (Cheng et al., 2002; Moyer et al., 1999; Moyer 
et al., 2000) and diffusional mobility (Haggie et al., 2004), links CFTR to upstream 
regulators and downstream effectors (Naren et al., 2003; Puchelle et al., 2002), potentiates 
channel function (Raghuram et al., 2003; Raghuram et al., 2001; Wang et al., 2000) and 
plays a role in CFTR-mediated regulation of other cellular processes (Raghuram et al., 2003; 
Raghuram et al., 2001; Wang et al., 2000).  In addition, PDZ proteins accumulated on 
intracellular compartments, including the Golgi-associated proteins CAL (Cheng et al., 2002) 
and the endosomal associated SNX27 (unpublished data), may modulate various aspects of 
CFTR protein trafficking.     
Initial studies in epithelial cells suggested that PDZ proteins play a role in the apical 
polarization of CFTR.  In MDCK cells, Moyer et al. found that GFP-CFTR preferentially 
accumulates on the apical plasma membrane, while GFP-CFTR/∆TRL is unpolarized (Moyer 
et al., 1999).  These data led Moyer et al. to conclude that the CFTR PDZ binding motif is an 
apical targeting signal.  Furthermore, it was suggested that CFTR is initially delivered to both 
the apical and basolateral membranes and that the apical accumulation results from both 
increased apical delivery of CFTR from the endosomes and the interaction with actin-
associated apical PDZ proteins (Moyer et al., 1999).  However, three other groups have since 
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presented contradictory evidence which report that the PDZ binding motif is not required for 
the apical localization of CFTR.  In studies by Benharouga et al., Ostedgaard et al., and 
Milewski et al., the apical polarity of CFTR proteins with an extracellular HA-tag or 
untagged CFTR was maintained despite C-terminal truncations which delete the PDZ 
binding motif (Benharouga et al., 2003; Milewski et al., 2001; Ostedgaard et al., 2003).  Our 
data suggesting that CFTR is linked to the actin cytoskeleton via both the N- and C-terminus 
may help resolve this controversy.  In preliminary experiments, we find that GFP-CFTR does 
not efficiently interact with FLN-A, providing a potential explanation why GFP-
CFTR/∆TRL is equally distributed on the apical and basolateral membranes (Figure 4.16).  
Thus, we predict that the apical expression of CFTR requires an interaction with either 
filamins or PDZ proteins.  
If filamins do indeed play a role in the polarized expression of CFTR, they are likely 
to do so by regulating trafficking events and the stability of CFTR at the plasma membrane.  
Moyer et al. suggest that efficient recycling at the apical, but not basolateral membranes, 
significantly contributes to the apical accumulation of CFTR (Moyer et al., 2000).  In 
unpolarized cells, we find that internalized S13F CFTR accumulates in lysosomes 3-times 
faster than wild-type CFTR (8 hours versus 24 hours).  These data are consistent with a role 
for filamins in the endocytic trafficking and recycling of CFTR.  In addition, we find that 
filamins regulate the surface expression of CFTR.  The plasma membrane pool of S13F 
CFTR is significantly less than that of wild-type CFTR.  Moreover, the surface expression of 
wild-type CFTR is likewise reduced in M2 cells which lack FLN-A or in the presence of 
peptides which complete for filamin binding.  Taken together, our data suggest that filamins, 
like PDZ proteins, may regulate processes important for the retention of CFTR at the apical 
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membrane including efficient endocytic recycling and cell surface stability.  In future 
experiments we will test the requirement of filamins and PDZ proteins for the apical 
localization of CFTR.  We will express CFTR mutants which cannot bind to filamins (S13F 
CFTR), PDZ proteins (∆TRL CFTR), or both filamins and PDZ proteins (S13F/∆TRL 
CFTR).  We predict that disrupting the interaction between CFTR and filamins or PDZ 
proteins will not alter the apical distribution of CFTR, while the S13F/∆TRL CFTR double 
mutant will be unpolarized (Figure 4.16).  
In addition to a potential role in the apical retention of CFTR, filamins may also 
participate in the regulation of CFTR activity.   For example, filamins may indirectly regulate 
CFTR activity by competing with other N-terminal interactions involved in channel gating.  
It is not clear how filamin binding to the CFTR affects the interaction with syntaxins or the 
intra-molecular interaction between the CFTR N-terminus and R-domain.  However, 
competing with either interaction would be predicted to alter channel gating.  Therefore, we 
will monitor CFTR channel activity in patch clamp experiments in which we compare the 
gating of wild-type and S13F CFTR expressed in epithelial cells.   
Filamins may also regulate the CFTR activity by clustering the channel in the plasma 
membrane.  By indirect immunofluorescence, Kir 2.1 (Sampson et al., 2003) and HCN1 
(Gravante et al., 2004; Li et al., 2000) were observed to be clustered into “hotspots” at the 
cell surface in FLN-A expressing A7 cells but not FLN-A null M2 cells.  Furthermore, 
mutations which disrupt FLN-A binding in the D2-dopamine receptor impair dopamine-
mediated inhibition of adenylyl cyclase, which may result from decreased receptor clustering 
(Li et al., 2000).  Numerous studies have addressed whether CFTR functions as a monomer  
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Figure 4.16.  An N-terminal GFP fusion blocks filamin binding to CFTR.   
Untagged or GFP-tagged CFTR was immunoprecipitated from HEK293 cells.  Bound 
proteins were separated by SDS-PAGE and analyzed by western blot using FLN-A antisera.  
Although equal amounts of WT and GFP-tagged CFTR were immunoprecipitated (Top left 
panel), the addition of the GFP tag to CFTR clearly decreases the ability of filamin to 
associate with the channel (Top right panel).   
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Figure 4.17.  A model of CFTR polarized trafficking 
The interaction with PDZ proteins at the CFTR C-terminus has been predicted to regulate the 
apical sorting of the channel in studies where CFTR is N-terminally tagged with GFP.  
However, this model is controversial as studies using untagged proteins find that CFTR does 
not require the PDZ binding motif for its apical polarity.  We hypothesize that the N-terminal 
interaction with filamin may reconcile this controversy.  We propose that filamins and PDZ 
proteins may coordinately regulate the apical sorting of CFTR.  Based on previous studies, 
we predict that mutations that disrupt filamin binding (S13F) or PDZ binding (∆TRL) will 
not individually alter the apical polarity of CFTR.  However, the double mutant 
(S13F/∆TRL) will be unpolarized. 
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or dimer in vivo, however, this remains a controversial topic.  Studies using 
electrophysiological, biochemical, and biophysical approaches have provided evidence for 
CFTR dimerization in vivo.  In patch-clamp experiments, the presence of multiple CFTR 
proteins in a single patch potentiates CFTR chloride channel activity (Fischer and Machen, 
1994; Pasyk and Foskett, 1995).  Furthermore, this cooperative gating has been observed to 
result in the simultaneous opening of CFTR channel pairs.  Ramjeesingh et al. combined the 
use of cell-impermeable cross-linkers with SDS-PAGE electrophoresis and size-exclusion 
chromatography to show that a pool of CFTR purified from intestinal epithelial cells 
migrates with a molecular weight consistent with a CFTR dimer (Ramjeesingh et al., 2003). 
Furthermore, (Eskandari et al., 1998) et al. examined CFTR proteins expressed in the plasma 
membrane of Xenopus oocytes by freeze fracture electron microscopy .  In these studies, the 
diameter of CFTR was consistent for a transmembrane protein with 24 transmembrane 
domains, suggesting that CFTR, which has 12 transmembrane domains, forms dimers in vivo.  
The PDZ protein NHERF-3 (PDZK1 or Cap70) has been proposed to facilitate dimerization 
by simultaneously binding to two CFTR proteins using PDZ domains 3 and 4 (Wang et al., 
2000).  While exogenous NHERF-3 can potentitate CFTR channel activity, it is not clear 
whether it can mediate dimerization between two full length CFTR proteins.  Filamins are 
also excellent candidates to regulate CFTR dimerization.  Filamins are known to function as 
dimers in vivo, and as such, may facilitate CFTR dimerization by compartmentalizing two 
channels in close proximity (Weihing, 1988).  In addition to organizing oligomeric CFTR 
complexes, filamins may also compartmentalize CFTR with upstream activators and 
downstream effectors.  In summary, filamins may also play a previously unrecognized role in 
regulating CFTR channel activity which may include directly regulating channel gating, 
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competing for an interaction with another regulatory factor, or compartmentalizing signaling 
molecules with CFTR.  In the following chapter we explore these topics in more depth and 
present preliminary data which suggest that filamins are required for efficient receptor-
mediated activation of CFTR.  
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Chapter 5:  Future directions 
 
 This dissertation describes the development of methods used to characterize protein-
protein interactions by mass spectrometry.  Using these methods we identified two novel 
CFTR binding proteins, the B’ε subunit of the serine/threonine phosphatase PP2A and the 
cytoskeletal protein filamin.  While many regulatory factors have been identified for CFTR, 
it is not clear which ones are relevant in epithelial tissues or how they are organized.  Our 
work demonstrates that PP2A is a relevant CFTR phosphatase in airway and intestinal 
epithelia.  Furthermore, we provide a mechanism by which PP2A, via the B’ε regulatory 
subunit is compartmentalized with CFTR.  Our studies on filamins suggest that these proteins 
anchor CFTR to the cytoskeleton and regulate the plasma membrane stability and endocytic 
trafficking of CFTR.  In the following discussion, we explore the implications of these 
interactions in terms of cell signaling specificity and channel regulation. 
CFTR channel gating reflects a balance between the activities of endogenous kinases 
and phosphatases.  The phosphorylation of the CFTR R-domain on multiple serine residues 
increases channel gating.  While PKA is the dominant activator of CFTR (Chang et al., 1993; 
Cheng et al., 1991; Seibert et al., 1995), it is clear that multiple kinases including PKC 
(Berger et al., 1993; Chappe et al., 2003; Fischer et al., 1998; Fouassier et al., 2005; Liedtke 
et al., 2002) and cGMP-dependent kinase II (Berger et al., 1993) stimulates channel activity; 
while the AMP-dependent kinase has been shown to negatively regulate CFTR (Hallows et 
al., 2000).  Still less is known regarding the dephosphorylation of CFTR in epithelia.  
Multiple phosphatases including PP2A, PP2B, and PP2C dephosphorylate and functionally 
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regulate CFTR (Fischer et al., 1998; Hwang et al., 1993; Luo et al., 1998; Reddy and 
Quinton, 1996; Travis et al., 1997).    
 In the future it will be important to understand how individual phosphorylation sites 
on CFTR are regulated by specific kinases and phosphatases and how these sites affect 
channel activity.  The recent development of several phospho-specific CFTR antibodies by 
the laboratory of Jack Riordan provides important reagents for studying the functional 
significance of individual phosphorylation sites on CFTR.  These antibodies recognize 
epitopes in the CFTR R-domain which are lost when serine residues in the epitope are 
phosphorylated.  In preliminary experiments, the dephosphorylation of maximally activated 
CFTR was monitored in BHK cells.  The dephosphorylation of serine residues 737 and 813 is 
blocked by the presence of PP2A inhibitors; however, the kinetics of dephosphorylation of 
other serine residues are not affected.  Interestingly, CFTR proteins lacking the last 40 amino 
acids (CFTR∆40), which includes the PP2A binding site we identified, is dephosphorylated 
similarly to CFTR in the presence of PP2A inhibitors.  That is, serine residues 737 and 813 
are not dephosphorylated on the CFTR∆40 protein (Tamas Hedges, personal 
communication).  In addition to supporting our observation that PP2A is associated with the 
CFTR C-terminus, these data suggest that specific phosphatases will mediate the 
dephosphorylation of specific residues on CFTR. 
In addition to regulating channel function, phosphorylation/dephosphorylation may 
regulate other aspects of CFTR biology.  Studies with other transmembrane proteins 
demonstrate that phosphorylation can regulate protein-protein interactions, trafficking events, 
and target proteins for degradation.  For example, the IL-6 receptor subunit, gp130, is 
degraded in response to phosphorylation at serine 782 (Mitsuhashi et al., 2005). PP2A 
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antagonizes the phosphorylation dependent degradation, as okadaic acid, a PP2A inhibitor 
accelerates the turnover of gp130. Additionally, a number of transmembrane proteins 
including TRPP2 (Kottgen et al., 2005), human cytomegalovirus glycoprotein B (Crump et 
al., 2003), and PC6B (Xiang et al., 2000) bind to the adaptor proteins PACS-1 or 2 which 
regulate protein trafficking in the TGN and endosomal compartments. The binding of PACS 
proteins to transmembrane cargo is regulated by casein kinase II phosphorylation of both 
PACS and the cargo molecule (Molloy et al., 1998; Scott et al., 2003). Furthermore, PP2A 
can disrupt the PACS/cargo interaction via dephosphorylation to regulate these trafficking 
events.  Although not previously demonstrated for CFTR, the interaction between CFTR and 
PP2A may be important for regulating a previously unrecognized aspect of CFTR biology.   
The phosphorylation of CFTR may also regulate its interaction with filamins.  We 
find that the substitution of serine 13 to acidic residues, S13D and S13E, commonly used to 
mimic serine phosphorylation, showed reduced binding to FLN-A by immunoprecipitation 
(Figure 4.8A). It is intriguing to speculate that this interaction is regulated by 
phosphorylation, although serine 13 is not contained within an obvious phosphorylation 
motif.  For other filamin binding proteins including GPIbα (Meyer et al., 1997), β-integrins 
(Sharma et al., 1995), and the high affinity immunoglobulin receptor (Ohta et al., 1991), 
ligand engagement results in the disassociation of filamin binding.  One possibility is that, at 
the plasma membrane, the activation state of CFTR may regulate filamin binding.  In future 
experiments, we will examine filamin binding in the presence of factors that stimulate CFTR 
activity, such as adenosine and forskolin.  Alternatively, the CFTR-filamin interaction may 
be regulated by calcium signaling.  To date, calcium is the best characterized regulator of 
filamins.  Increases in intracellular calcium cause the disassociation of filamin from actin in a 
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calmodulin dependent manner (Nakamura et al., 2005a).  Furthermore, the hinge regions of 
filamin are sensitive to cleavage by the calcium dependent protease, calpain (Azam et al., 
2001; Kwak et al., 1993; Onji et al., 1987).  In preliminary studies, we find that calmodulin 
can directly associate with the CFTR[1-25] peptide which also binds filamins.  Calmodulin 
(1 µg) was incubated with the indicated peptides for 30 minutes at 37ºC.  Calmodulin was 
then resolved using native acrylamide gel electrophoresis and visualized using coomassie 
blue.  Peptide binding is observed as an increase in the apparent molecular weight of 
calmodulin.  We observe an increase in the apparent molecular weight of calmodulin at all 
concentrations tested for a peptide corresponding to the calmodulin binding domain of the 
calmodulin-dependent protein kinase (CaM kinase), which is known to interact with 
calmodulin with a nanomolar affinity (Figure 5.1A).  Furthermore, we observe concentration 
dependent binding of the CFTR[1-25] peptide, but not another N-terminal peptide, CFTR[42-
66].  Calmodulin interacts with CFTR in a calcium-dependent manner with a micromolar 
affinity (Kd = 1.6 µM) (Figure 5.1B).  The CFTR-calmodulin interaction has not been 
validated in vivo, but offers an interesting mechanism by which the CFTR-filamin interaction 
may be regulated.     
While we have not yet explored a scaffolding role for filamins, it is likely that 
filamins also recruit additional regulatory factors into a complex with CFTR.  This is a 
reasonable hypothesis because filamins are known to compartmentalize receptors and ion 
channels with signal transduction elements.  For example, the interaction between FLN-A 
and β-integrins is critical for the formation of focal adhesions following extracellular matrix 
engagement.  FLN-A provides integrins with a direct link to the actin and recruits 
cytoskeletal regulatory proteins such as Rho, Rac, CDC42, RalA, Trio, and PAK to the  
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Figure 5.1.  Calmodulin can also interact with the CFTR N-terminus 
A. Calmodulin (1 µg) was incubated with CFTR[1-25], CFTR[42-66] calmodulin binding 
domain peptides at the indicated molar excess.  Calmodulin was separated on a non-
denaturing acrylamide gels and visualized by coomassie blue staining.  The CFTR[1-25] 
peptide clearly interacts with calmodulin as, at increasing concentrations of peptide, 
calmodulin is observed to increase in molecular weight.  Calmodulin does not bind to 
CFTR[42-66] at any concentration tested.  Calmodulin is completely bound to the CaM 
kinase peptide at all concentrations.  This is not surprising given the high affinity for this 
interaction (Kd ranges from 2 and 0.02 nM).  B. The interaction between CFTR[1-25] and 
calmodulin was analyzed by SPR.  Calmodulin interacts with CFTR in a concentration 
dependent manner with an a Kd = 1.6 µM.  No binding was observed for the CFTR[42-66] 
peptide.  Furthermore, no binding was observed in the absence of calcium.  As such, all 
assays were done in the presence of 500 nM calcium.   
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complex (Stossel et al., 2001).  Recently, Tu et al. identified additional components of the 
FLN-A and β-integrin complex (Tu et al., 2003).  The mitogen-inducible gene-2 (Mig-2) 
recruits the LIM domain-containing protein migfilin to FLN-A which is required for ECM-
dependent cell spreading.  Thus, filamins function as scaffolding proteins to link extracellular 
and intracellular signaling events by coupling receptor activation to cytosolic signal 
transduction and cytoskeletal rearrangements.  
In future studies we will explore the role of filamins in the regulation of CFTR 
channel activity in polarized epithelial cells.  In preliminary experiments, we studied CFTR 
channel activity in Xenopus oocytes, a heterologous system where S13F CFTR is efficiently 
processed (Figure 5.2A).  We first confirmed that filamins are expressed in oocytes and were 
able to bind human CFTR. Using the CFTR[1-25] and CFTR[1-25/S13F] peptides in pull-
down assays from oocyte cell extracts, we find a high molecular weight band, consistent with 
the size of human FLNs, purified with CFTR[1-25] but not CFTR[1-25/S13F] (Figure 5.2B). 
This band was excised, digested with trypsin, and analyzed by nano-electrospray MS/MS.  
Using the tandem MS spectra, we derived the amino acid sequences from five of the peptides 
analyzed.  When searched against human protein databases, the Xenopus peptide sequences 
matched hFLN-A (~80% identical). Therefore, we proceeded with functional studies to 
compare basal and stimulated CFTR currents in injected oocytes.  Interestingly, S13F CFTR 
functions differed from WT CFTR in two ways. First, S13F CFTR maximal currents 
stimulated by forskolin/IBMX were decreased by ~45% relative to wild-type CFTR (Figure 
5.2C).  This is consistent with our data presented in chapter 4 which demonstrate that 
filamins regulate the surface expression of CFTR.  We also examined CFTR channel activity 
stimulated by a relevant receptor signaling pathway by co-injecting the β2-adrenergic 
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receptor in oocytes.  The β2-adrenergic receptor potently stimulates CFTR via adenylyl 
cyclase activation which increases cAMP and results in PKA phosphorylation of CFTR 
(Uezono et al., 1993).  We find that the fractional stimulation of S13F CFTR through 
activation of co-injected β2-adrenergic receptor was 40% compared to 78% for wild-type and 
S13A CFTR (Figure 1C).  Despite potential difference between the number of wild-type and 
S13F CFTR channels on the cell surface, these data indicate that S13F CFTR is less 
responsive to activation via a receptor mediated pathway.   
It is intriguing to speculate that filamins may compartmentalize CFTR with upstream 
activators.  Our lab has previously shown that the cellular machinery capable of generating 
cAMP, including the adenosine receptor and membrane bound adenylate cyclases, are 
compartmentalized with CFTR in the apical membrane of airway epithelia.  Given that 
filamins directly associate with numerous G-protein coupled receptors including the D2-
dopamine receptor (Li et al., 2000), calcitonin receptor (Seck et al., 2003), calcium-sensing 
receptor (Pi et al., 2002), and mu opioid receptor (Onoprishvili et al., 2003), it will be 
important to ask whether receptors relevant to CFTR, such as β2-adrenergic or adenosine 
receptors also bind to filamins. 
 Filamins may also regulate CFTR by spatially confining the channel in the plasma 
membrane.  By SPT, we observe that CFTR is mobile on the cell surface, but undergoes 
periods of transient confinement.  The importance of these transient confinements is not well 
understood.  An emerging hypothesis is that receptors and signaling molecules are 
compartmentalized in membrane micro-domains, which are regulated by the lipid 
composition of the plasma membrane and the underlying cytoskeleton (Kusumi and Sako, 
1996; Sheets et al., 1997).  Perhaps the most well characterized membrane micro-domains  
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Figure 5.2 . CFTR requires filamin binding for efficient receptor mediated activation  
(A) Representative oocytes were lysed and analyzed for CFTR expression by western blot.  
Both WT and S13F CFTR are expressed at similar levels and there is no apparent difference 
in the ratio of maturely versus immaturely glycoslyated forms.  (B) The CFTR[1-25] peptide, 
but not the S13F mutant, interacts with a Xenopus protein identified by mass spectrometry to 
be >80% homologous to human filamin (C) CFTR chloride conductance was measured by 
two-electrode voltage clamp in Xenopus oocytes expressing either wild-type or S13F CFTR 
and the β2AR.  CFTR activation was measured following β2AR stimulation (Isoproterenol, 
open bars) followed by treatment with IBMX/forskolin.  White bars represent maximal 
CFTR activity (Isoproterenol response + IBMX/forskolin). 
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are lipid rafts.  However, the exact nature of this compartment remains elusive, suggesting 
that rafts are highly dynamic.  Current hypotheses suggest that lipid rafts are compartments 
enriched in cholesterol, GPI-anchored proteins, signaling molecules such as Src kinases, and 
caveolin (Anderson and Jacobson, 2002).  Like other GPI-anchored proteins, we find that 
CFTR is compartmentalized into TCZ.  Although this is some evidence for the partitioning of 
CFTR into lipid rafts, we find that cholesterol depletion or Src kinase inhibition, maneuvers 
that inhibit the transient confinement of raft proteins, have no effect on CFTR confinement 
(data not shown).  Furthermore, we do find that disrupting filamin binding to CFTR, using 
the S13F mutant, significantly disrupts the transient confinement of CFTR.  Thus, we 
hypothesize that the confinement of CFTR is coordinated by interactions with the 
cytoskeleton.  An interesting hypothesis is that the transient confinement of CFTR represents 
the compartmentalization of the channel with regulatory proteins.  It will be interesting to 
examine whether the confinement of CFTR in TCZs correlates with changes in channel 
activity. 
In addition to the studying how filamins individually regulate CFTR, we are also 
interested in how they cooperate with other CFTR-interacting proteins.  In chapter 4, we 
proposed a model for the apical polarity of CFTR which depends upon a dual N- and C-
terminal protein interaction.  We also predict that filamins and PDZ proteins may 
coordinately regulate the membrane mobility of CFTR and its organization with signaling 
molecules.  We are continuing to study CFTR by SPT and are examining how the CFTR 
confinement dually regulated by N- and C-terminal cytoskeletal attachments.  Interestingly, 
more than half of the ion channels and receptors identified as filamin binding proteins also  
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Table 3.  Filamins and PDZ proteins may coordinately regulate their binding partners 
A table of all known filamin binding proteins which additionally interact, or are predicted to 
interact, with PDZ proteins.  References:  (Bomberger et al., 2005; Enz, 2002; Enz and Croci, 
2003; Gupta et al., 2004; Jeanneteau et al., 2004; Leonoudakis et al., 2004; Leonoudakis et 
al., 2001; Li et al., 2000; Liu et al., 1997; Nehring et al., 2000; Sampson et al., 2003; Seck et 
al., 2003; Short et al., 1998; Sun et al., 2000b; Wang et al., 2000; Xu et al., 1999; Zhang et 
al., 1998). 
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contain PDZ binding motifs (Table 3).  Thus, filamins and PDZ proteins may coordinately 
regulate the activities and membrane trafficking of their binding partners. 
 In summary, we have presented evidence that CFTR is regulated by direct 
interactions with PP2A and filamins.  In addition to furthering our understanding of normal 
CFTR physiology, the PP2A and filamin interactions may provide useful insights for the 
design of future therapeutic approaches aimed at treating CF.  For example, there is a 
growing interest in developing pharmacological treatments, such as chemical chaperones, 
which stabilize folding mutants like ∆F508 CFTR, allowing them to exit the ER.  In cell 
culture models, rescued ∆F508 CFTR reaches the cell surface and has chloride channel 
activity (Denning et al., 1992).  However, several studies have demonstrated that rescued 
∆F508 CFTR does not function to the capacity of the wild-type channel due to altered gating 
and decreased plasma membrane stability (Gentzsch et al., 2004; Swiatecka-Urban et al., 
2005a; Swiatecka-Urban et al., 2005b).  These defects highlight our need to understand the 
processes which regulate CFTR activity, trafficking, and surface expression.  Given that 
PP2A inhibition increases CFTR channel activity and ASL height in primary airway 
epithelia, this enzyme may provide a good drug target to augment the activity of mutant 
channels (Thelin et al., 2005).  Furthermore, targeting signaling pathways that favor the 
CFTR-filamin interaction may promote retention of the channel at the cell surface.  Thus, in 
future experiments it will be important to study these interactions in the context of mutant 
CFTR proteins in polarized epithelia.  
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